AP919A - Metal chelate complexes for foming oxidation catalyst. - Google Patents
Metal chelate complexes for foming oxidation catalyst. Download PDFInfo
- Publication number
- AP919A AP919A APAP/P/1999/001455A AP9901455A AP919A AP 919 A AP919 A AP 919A AP 9901455 A AP9901455 A AP 9901455A AP 919 A AP919 A AP 919A
- Authority
- AP
- ARIPO
- Prior art keywords
- group
- complex
- metal
- amino
- recited
- Prior art date
Links
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 66
- 230000003647 oxidation Effects 0.000 title claims abstract description 62
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 55
- 239000002184 metal Substances 0.000 title claims abstract description 53
- 239000013522 chelant Substances 0.000 title claims abstract description 31
- 239000003054 catalyst Substances 0.000 title abstract description 27
- 239000003446 ligand Substances 0.000 claims abstract description 83
- 125000001424 substituent group Chemical group 0.000 claims abstract description 40
- 125000004429 atom Chemical group 0.000 claims abstract description 26
- 150000002367 halogens Chemical class 0.000 claims abstract description 22
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 22
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 21
- 239000001257 hydrogen Substances 0.000 claims abstract description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 17
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 15
- 150000003624 transition metals Chemical class 0.000 claims abstract description 14
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001301 oxygen Substances 0.000 claims abstract description 11
- 150000004697 chelate complex Chemical class 0.000 claims abstract description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract 7
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 4
- -1 amino, substituted amino Chemical group 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 44
- 125000003118 aryl group Chemical group 0.000 claims description 35
- 230000001590 oxidative effect Effects 0.000 claims description 32
- 238000010525 oxidative degradation reaction Methods 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000004122 cyclic group Chemical group 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 12
- 125000000524 functional group Chemical group 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 238000005304 joining Methods 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 7
- 150000004696 coordination complex Chemical class 0.000 claims description 7
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 150000002978 peroxides Chemical class 0.000 claims description 6
- 230000000536 complexating effect Effects 0.000 claims description 5
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000004104 aryloxy group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 230000000737 periodic effect Effects 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- KYPOHTVBFVELTG-OWOJBTEDSA-N (e)-but-2-enedinitrile Chemical compound N#C\C=C\C#N KYPOHTVBFVELTG-OWOJBTEDSA-N 0.000 claims 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 229910052741 iridium Inorganic materials 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 229910052750 molybdenum Inorganic materials 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- 229910052762 osmium Inorganic materials 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 229910052702 rhenium Inorganic materials 0.000 claims 1
- 229910052703 rhodium Inorganic materials 0.000 claims 1
- 229910052707 ruthenium Inorganic materials 0.000 claims 1
- 229910052713 technetium Inorganic materials 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 229910052721 tungsten Inorganic materials 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 51
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 47
- 239000000543 intermediate Substances 0.000 description 45
- 150000001408 amides Chemical class 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 37
- 239000000047 product Substances 0.000 description 34
- 239000002904 solvent Substances 0.000 description 34
- 239000000203 mixture Substances 0.000 description 33
- 238000003786 synthesis reaction Methods 0.000 description 33
- 125000005647 linker group Chemical group 0.000 description 32
- 230000015572 biosynthetic process Effects 0.000 description 31
- 239000000243 solution Substances 0.000 description 31
- 239000007800 oxidant agent Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000007858 starting material Substances 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 150000004985 diamines Chemical class 0.000 description 21
- 125000004043 oxo group Chemical group O=* 0.000 description 21
- 150000001412 amines Chemical class 0.000 description 19
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 18
- 150000002500 ions Chemical class 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 16
- 238000005859 coupling reaction Methods 0.000 description 16
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 15
- 238000006467 substitution reaction Methods 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 14
- 229910021645 metal ion Inorganic materials 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 125000000623 heterocyclic group Chemical group 0.000 description 11
- 150000001540 azides Chemical class 0.000 description 10
- 150000002825 nitriles Chemical class 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 9
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 230000010933 acylation Effects 0.000 description 8
- 238000005917 acylation reaction Methods 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 238000005710 macrocyclization reaction Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- 238000006555 catalytic reaction Methods 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 150000002576 ketones Chemical class 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 125000005605 benzo group Chemical group 0.000 description 6
- 150000001735 carboxylic acids Chemical class 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000007822 coupling agent Substances 0.000 description 6
- 125000000392 cycloalkenyl group Chemical group 0.000 description 6
- 150000002466 imines Chemical class 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000010189 synthetic method Methods 0.000 description 6
- MLVIMJJNLIMRCJ-UHFFFAOYSA-N 2,4-diamino-2,4-dimethylpentan-3-one Chemical compound CC(C)(N)C(=O)C(C)(C)N MLVIMJJNLIMRCJ-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000010511 deprotection reaction Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 150000002690 malonic acid derivatives Chemical class 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000006798 ring closing metathesis reaction Methods 0.000 description 5
- 238000007363 ring formation reaction Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical class CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 5
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- CJXQAYQWVNXIQE-UHFFFAOYSA-N 2,2-dimethylpropanedioyl dichloride Chemical compound ClC(=O)C(C)(C)C(Cl)=O CJXQAYQWVNXIQE-UHFFFAOYSA-N 0.000 description 4
- RIYSFSQPHCAGLS-UHFFFAOYSA-N 2-amino-3,5-dinitrobenzonitrile Chemical compound NC1=C(C#N)C=C([N+]([O-])=O)C=C1[N+]([O-])=O RIYSFSQPHCAGLS-UHFFFAOYSA-N 0.000 description 4
- UJOYFRCOTPUKAK-UHFFFAOYSA-N 3-ammonio-3-phenylpropanoate Chemical compound [O-]C(=O)CC([NH3+])C1=CC=CC=C1 UJOYFRCOTPUKAK-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 125000003003 spiro group Chemical group 0.000 description 4
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 4
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 4
- KPIVDNYJNOPGBE-UHFFFAOYSA-N 2-aminonicotinic acid Chemical compound NC1=NC=CC=C1C(O)=O KPIVDNYJNOPGBE-UHFFFAOYSA-N 0.000 description 3
- IKMZGACFMXZAAT-UHFFFAOYSA-N 4-methyl-3-nitropyridin-2-amine Chemical compound CC1=CC=NC(N)=C1[N+]([O-])=O IKMZGACFMXZAAT-UHFFFAOYSA-N 0.000 description 3
- BBTNLADSUVOPPN-UHFFFAOYSA-N 5,6-diaminouracil Chemical compound NC=1NC(=O)NC(=O)C=1N BBTNLADSUVOPPN-UHFFFAOYSA-N 0.000 description 3
- ZJKGRSJMFDIRPX-UHFFFAOYSA-N 5-methyl-3-nitropyridin-2-amine Chemical compound CC1=CN=C(N)C([N+]([O-])=O)=C1 ZJKGRSJMFDIRPX-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102100040141 Aminopeptidase O Human genes 0.000 description 3
- 108050008333 Aminopeptidase O Proteins 0.000 description 3
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- 229910004373 HOAc Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-FIBGUPNXSA-N acetonitrile-d3 Chemical compound [2H]C([2H])([2H])C#N WEVYAHXRMPXWCK-FIBGUPNXSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000006701 autoxidation reaction Methods 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 150000004700 cobalt complex Chemical class 0.000 description 3
- 238000001360 collision-induced dissociation Methods 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 3
- 229910003002 lithium salt Inorganic materials 0.000 description 3
- 159000000002 lithium salts Chemical class 0.000 description 3
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 150000004032 porphyrins Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012041 precatalyst Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- RXCOGDYOZQGGMK-UHFFFAOYSA-N (3,4-diaminophenyl)-phenylmethanone Chemical compound C1=C(N)C(N)=CC=C1C(=O)C1=CC=CC=C1 RXCOGDYOZQGGMK-UHFFFAOYSA-N 0.000 description 2
- LRMDXTVKVHKWEK-UHFFFAOYSA-N 1,2-diaminoanthracene-9,10-dione Chemical compound C1=CC=C2C(=O)C3=C(N)C(N)=CC=C3C(=O)C2=C1 LRMDXTVKVHKWEK-UHFFFAOYSA-N 0.000 description 2
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 2
- PCAXITAPTVOLGL-UHFFFAOYSA-N 2,3-diaminophenol Chemical compound NC1=CC=CC(O)=C1N PCAXITAPTVOLGL-UHFFFAOYSA-N 0.000 description 2
- BZHMBWZPUJHVEE-UHFFFAOYSA-N 2,4-dimethylpentane Chemical compound CC(C)CC(C)C BZHMBWZPUJHVEE-UHFFFAOYSA-N 0.000 description 2
- ZYTAWRJYVOUJBP-UHFFFAOYSA-N 2-amino-4,6-dimethylpyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.CC1=CC(C)=C(C(O)=O)C(N)=N1 ZYTAWRJYVOUJBP-UHFFFAOYSA-N 0.000 description 2
- LHRIICYSGQGXSX-UHFFFAOYSA-N 2-chloro-4,6-dinitroaniline Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1[N+]([O-])=O LHRIICYSGQGXSX-UHFFFAOYSA-N 0.000 description 2
- XFXOLBNQYFRSLQ-UHFFFAOYSA-N 3-amino-2-naphthoic acid Chemical compound C1=CC=C2C=C(C(O)=O)C(N)=CC2=C1 XFXOLBNQYFRSLQ-UHFFFAOYSA-N 0.000 description 2
- LYCCVBLUKJRDOF-UHFFFAOYSA-N 3-amino-4-nitrobenzoic acid Chemical compound NC1=CC(C(O)=O)=CC=C1[N+]([O-])=O LYCCVBLUKJRDOF-UHFFFAOYSA-N 0.000 description 2
- WGLQHUKCXBXUDV-UHFFFAOYSA-N 3-aminophthalic acid Chemical compound NC1=CC=CC(C(O)=O)=C1C(O)=O WGLQHUKCXBXUDV-UHFFFAOYSA-N 0.000 description 2
- ZAGZIOYVEIDDJA-UHFFFAOYSA-N 3-aminopyrazine-2-carboxylic acid Chemical compound NC1=NC=CN=C1C(O)=O ZAGZIOYVEIDDJA-UHFFFAOYSA-N 0.000 description 2
- SKIUVOVOIJBJPN-UHFFFAOYSA-N 4,5-dimethoxybenzene-1,2-diamine Chemical compound COC1=CC(N)=C(N)C=C1OC SKIUVOVOIJBJPN-UHFFFAOYSA-N 0.000 description 2
- YBPNIILOUYAGIF-UHFFFAOYSA-N 4-amino-2-methylpyrimidine-5-carbonitrile Chemical compound CC1=NC=C(C#N)C(N)=N1 YBPNIILOUYAGIF-UHFFFAOYSA-N 0.000 description 2
- DPBQZIHMIPYKHX-UHFFFAOYSA-N 4-nitro-1h-imidazol-5-amine Chemical compound NC=1NC=NC=1[N+]([O-])=O DPBQZIHMIPYKHX-UHFFFAOYSA-N 0.000 description 2
- PWRHKLKFADDKHS-UHFFFAOYSA-N 5,6-diamino-1h-pyrimidin-4-one Chemical compound NC=1NC=NC(=O)C=1N PWRHKLKFADDKHS-UHFFFAOYSA-N 0.000 description 2
- FFNKBQRKZRMYCL-UHFFFAOYSA-N 5-amino-1h-pyrazole-4-carbonitrile Chemical compound NC1=NNC=C1C#N FFNKBQRKZRMYCL-UHFFFAOYSA-N 0.000 description 2
- QOOCOFOGYRQPPN-UHFFFAOYSA-N 5-bromo-3-nitropyridin-2-amine Chemical compound NC1=NC=C(Br)C=C1[N+]([O-])=O QOOCOFOGYRQPPN-UHFFFAOYSA-N 0.000 description 2
- MRCFKNAXRGITFV-UHFFFAOYSA-N 6,7-dinitroquinoxaline Chemical compound C1=CN=C2C=C([N+]([O-])=O)C([N+](=O)[O-])=CC2=N1 MRCFKNAXRGITFV-UHFFFAOYSA-N 0.000 description 2
- UOWCFGBLAMCSFY-UHFFFAOYSA-N 6-amino-5-nitroso-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound NC=1NC(=S)NC(=O)C=1N=O UOWCFGBLAMCSFY-UHFFFAOYSA-N 0.000 description 2
- TYBYHEXFKFLRFT-UHFFFAOYSA-N 6-nitroquinolin-5-amine Chemical compound C1=CC=C2C(N)=C([N+]([O-])=O)C=CC2=N1 TYBYHEXFKFLRFT-UHFFFAOYSA-N 0.000 description 2
- XYPMAZCBFKBIFK-UHFFFAOYSA-N 9,10-dinitroanthracene Chemical compound C1=CC=C2C([N+](=O)[O-])=C(C=CC=C3)C3=C([N+]([O-])=O)C2=C1 XYPMAZCBFKBIFK-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 229960001413 acetanilide Drugs 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 238000010640 amide synthesis reaction Methods 0.000 description 2
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000001721 carboxyacetyl group Chemical group 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 229950011148 cyclopropane Drugs 0.000 description 2
- 125000004427 diamine group Chemical group 0.000 description 2
- 229940117389 dichlorobenzene Drugs 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- ZIYVHBGGAOATLY-UHFFFAOYSA-N methylmalonic acid Chemical compound OC(=O)C(C)C(O)=O ZIYVHBGGAOATLY-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- UTVPMPDZZSTVJW-UHFFFAOYSA-N n-(3,4-diaminophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C(N)=C1 UTVPMPDZZSTVJW-UHFFFAOYSA-N 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Substances [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 2
- 150000003904 phospholipids Chemical group 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000012048 reactive intermediate Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- WGECXQBGLLYSFP-UHFFFAOYSA-N (+-)-2,3-dimethyl-pentane Natural products CCC(C)C(C)C WGECXQBGLLYSFP-UHFFFAOYSA-N 0.000 description 1
- HONKEGXLWUDTCF-YFKPBYRVSA-N (2s)-2-amino-2-methyl-4-phosphonobutanoic acid Chemical compound OC(=O)[C@](N)(C)CCP(O)(O)=O HONKEGXLWUDTCF-YFKPBYRVSA-N 0.000 description 1
- PQWHYMIYFPATGG-UHFFFAOYSA-N (4-amino-5-oxo-1,2-dihydropyrazol-3-yl)azanium;hydrogen sulfate Chemical compound OS(O)(=O)=O.NC=1NNC(=O)C=1N PQWHYMIYFPATGG-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- OVFWWDRGWIAOIT-UHFFFAOYSA-N 1,2,3,4-tetramethyl-5,6-dinitrobenzene Chemical compound CC1=C(C)C(C)=C([N+]([O-])=O)C([N+]([O-])=O)=C1C OVFWWDRGWIAOIT-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- WOXWUZCRWJWTRT-UHFFFAOYSA-N 1-amino-1-cyclohexanecarboxylic acid Chemical compound OC(=O)C1(N)CCCCC1 WOXWUZCRWJWTRT-UHFFFAOYSA-N 0.000 description 1
- NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 1
- PIUDKRWICUMHFJ-UHFFFAOYSA-N 1-methoxy-2-(nitromethoxy)benzene Chemical compound COC1=CC=CC=C1OC[N+]([O-])=O PIUDKRWICUMHFJ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- GHXNRYVDXNZXID-UHFFFAOYSA-N 2,2-diethylbutanoic acid Chemical compound CCC(CC)(CC)C(O)=O GHXNRYVDXNZXID-UHFFFAOYSA-N 0.000 description 1
- FWKCXFPQSXNCBW-UHFFFAOYSA-N 2,2-diethylpropanedioyl dichloride Chemical compound CCC(CC)(C(Cl)=O)C(Cl)=O FWKCXFPQSXNCBW-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- BSUSGJKEVOQESO-UHFFFAOYSA-N 2,5-dimethyl-4-nitropyrazol-3-amine Chemical compound CC1=NN(C)C(N)=C1[N+]([O-])=O BSUSGJKEVOQESO-UHFFFAOYSA-N 0.000 description 1
- GVOYKJPMUUJXBS-UHFFFAOYSA-N 2-(aminomethyl)aniline Chemical class NCC1=CC=CC=C1N GVOYKJPMUUJXBS-UHFFFAOYSA-N 0.000 description 1
- HIGGFWFRAWSMBR-UHFFFAOYSA-N 2-Methyl-3-hexanone Chemical compound CCCC(=O)C(C)C HIGGFWFRAWSMBR-UHFFFAOYSA-N 0.000 description 1
- QHSCIWIRXWFIGH-UHFFFAOYSA-N 2-amino-2-methylpentanedioic acid Chemical compound OC(=O)C(N)(C)CCC(O)=O QHSCIWIRXWFIGH-UHFFFAOYSA-N 0.000 description 1
- XIEBABCZBKPITH-UHFFFAOYSA-N 2-amino-3-nitrofluoren-9-one Chemical compound O=C1C2=CC=CC=C2C2=C1C=C(N)C([N+]([O-])=O)=C2 XIEBABCZBKPITH-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- WIFSDCDETBPLOR-UHFFFAOYSA-N 2-aminobenzoic acid Chemical compound NC1=CC=CC=C1C(O)=O.NC1=CC=CC=C1C(O)=O WIFSDCDETBPLOR-UHFFFAOYSA-N 0.000 description 1
- QAHUDENYBOPMCG-UHFFFAOYSA-N 2-carboxy-3,6-dinitrobenzoate;pyridin-1-ium Chemical compound C1=CC=NC=C1.OC(=O)C1=C([N+]([O-])=O)C=CC([N+]([O-])=O)=C1C(O)=O QAHUDENYBOPMCG-UHFFFAOYSA-N 0.000 description 1
- VQDJODAWOFNASI-UHFFFAOYSA-N 2-propylpropanedioic acid Chemical compound CCCC(C(O)=O)C(O)=O VQDJODAWOFNASI-UHFFFAOYSA-N 0.000 description 1
- JZPHAJFIZZEAEK-UHFFFAOYSA-N 3-chloro-6-methoxy-2h-indazole Chemical compound COC1=CC=C2C(Cl)=NNC2=C1 JZPHAJFIZZEAEK-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- YHTLGFCVBKENTE-UHFFFAOYSA-N 4-methyloxan-2-one Chemical compound CC1CCOC(=O)C1 YHTLGFCVBKENTE-UHFFFAOYSA-N 0.000 description 1
- 229940044174 4-phenylenediamine Drugs 0.000 description 1
- OAPYCPXMCXWPHI-UHFFFAOYSA-N 5-amino-1-(4-nitrophenyl)pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1C1=CC=C([N+]([O-])=O)C=C1 OAPYCPXMCXWPHI-UHFFFAOYSA-N 0.000 description 1
- WXTHNWNCKJAQNU-UHFFFAOYSA-N 6,7-dimethoxy-1h-quinoxalin-2-one Chemical compound C1=C(O)N=C2C=C(OC)C(OC)=CC2=N1 WXTHNWNCKJAQNU-UHFFFAOYSA-N 0.000 description 1
- HEXGGXZMHVLAJV-UHFFFAOYSA-N 6,7-dinitro-2,3-diphenoxyquinoxaline Chemical compound C=1C=CC=CC=1OC=1N=C2C=C([N+]([O-])=O)C([N+](=O)[O-])=CC2=NC=1OC1=CC=CC=C1 HEXGGXZMHVLAJV-UHFFFAOYSA-N 0.000 description 1
- 150000005012 8-aminoquinolines Chemical class 0.000 description 1
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 description 1
- 150000000703 Cerium Chemical class 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001379910 Ephemera danica Species 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 238000001669 Mossbauer spectrum Methods 0.000 description 1
- ZOOHKAIIQYUNOS-UHFFFAOYSA-N N-(4-amino-3-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C([N+]([O-])=O)=C1.CC(=O)NC1=CC=C(N)C([N+]([O-])=O)=C1 ZOOHKAIIQYUNOS-UHFFFAOYSA-N 0.000 description 1
- 229910014299 N-Si Inorganic materials 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- DOYOSPHENDPKTP-UHFFFAOYSA-N OC(=O)CC(O)=O.CCOC(=O)C(C)(C(=O)OCC)c1ccccc1 Chemical compound OC(=O)CC(O)=O.CCOC(=O)C(C)(C(=O)OCC)c1ccccc1 DOYOSPHENDPKTP-UHFFFAOYSA-N 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Natural products C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229960004012 amifampridine Drugs 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940033495 antimalarials Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- PCCNIENXBRUYFK-UHFFFAOYSA-O azanium;cerium(4+);pentanitrate Chemical compound [NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O PCCNIENXBRUYFK-UHFFFAOYSA-O 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- LVRCYPYRKNAAMX-UHFFFAOYSA-M bis(triphenylphosphine)iminium chloride Chemical compound [Cl-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)N=P(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LVRCYPYRKNAAMX-UHFFFAOYSA-M 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- YQHLDYVWEZKEOX-UHFFFAOYSA-N cumene hydroperoxide Chemical compound OOC(C)(C)C1=CC=CC=C1 YQHLDYVWEZKEOX-UHFFFAOYSA-N 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- CCQPAEQGAVNNIA-UHFFFAOYSA-L cyclobutane-1,1-dicarboxylate(2-) Chemical compound [O-]C(=O)C1(C([O-])=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- NNDOHYGFLASMFR-UHFFFAOYSA-N diethyl 2,2-dipropylpropanedioate Chemical compound CCOC(=O)C(CCC)(CCC)C(=O)OCC NNDOHYGFLASMFR-UHFFFAOYSA-N 0.000 description 1
- ZQGOJSLHZOKIBV-UHFFFAOYSA-N diethyl 2-ethyl-2-pentan-2-ylpropanedioate Chemical compound CCCC(C)C(CC)(C(=O)OCC)C(=O)OCC ZQGOJSLHZOKIBV-UHFFFAOYSA-N 0.000 description 1
- PKRVDBARWFJWEB-UHFFFAOYSA-N diethyl 2-ethyl-2-phenylpropanedioate Chemical compound CCOC(=O)C(CC)(C(=O)OCC)C1=CC=CC=C1 PKRVDBARWFJWEB-UHFFFAOYSA-N 0.000 description 1
- DTHLCPJSRSNVLX-UHFFFAOYSA-N diethyl 2-methyl-2-propylpropanedioate Chemical compound CCOC(=O)C(C)(CCC)C(=O)OCC DTHLCPJSRSNVLX-UHFFFAOYSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- QWHNJUXXYKPLQM-UHFFFAOYSA-N dimethyl cyclopentane Natural products CC1(C)CCCC1 QWHNJUXXYKPLQM-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 150000003948 formamides Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- XDYHDLLKHFVVSE-UHFFFAOYSA-N hydrate;dihydrobromide Chemical compound O.Br.Br XDYHDLLKHFVVSE-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000004698 iron complex Chemical class 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000010667 large scale reaction Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 150000002691 malonic acids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- ZUVVLBGWTRIOFH-UHFFFAOYSA-N methyl 4-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoate Chemical compound COC(=O)C(CC(C)C)NS(=O)(=O)C1=CC=C(C)C=C1 ZUVVLBGWTRIOFH-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000005817 monooxygenase reaction Methods 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- IKPYZIYQKSMLQW-UHFFFAOYSA-N n-(3,4-diaminophenyl)acetamide;dihydrochloride Chemical compound Cl.Cl.CC(=O)NC1=CC=C(N)C(N)=C1 IKPYZIYQKSMLQW-UHFFFAOYSA-N 0.000 description 1
- MGVDUDAXURKVCE-UHFFFAOYSA-N n-(4-amino-3-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C([N+]([O-])=O)=C1 MGVDUDAXURKVCE-UHFFFAOYSA-N 0.000 description 1
- DYMRYCZRMAHYKE-UHFFFAOYSA-N n-diazonitramide Chemical compound [O-][N+](=O)N=[N+]=[N-] DYMRYCZRMAHYKE-UHFFFAOYSA-N 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000004987 o-phenylenediamines Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- SXYFKXOFMCIXQW-UHFFFAOYSA-N propanedioyl dichloride Chemical class ClC(=O)CC(Cl)=O SXYFKXOFMCIXQW-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010405 reoxidation reaction Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000003638 stannyl group Chemical group [H][Sn]([H])([H])* 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 description 1
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- WAGFXJQAIZNSEQ-UHFFFAOYSA-M tetraphenylphosphonium chloride Chemical compound [Cl-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WAGFXJQAIZNSEQ-UHFFFAOYSA-M 0.000 description 1
- 229940035024 thioglycerol Drugs 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/002—Osmium compounds
- C07F15/0026—Osmium compounds without a metal-carbon linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/1815—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
- B01J31/182—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/40—Regeneration or reactivation
- B01J31/4015—Regeneration or reactivation of catalysts containing metals
- B01J31/4023—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/70—Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/10—Complexes comprising metals of Group I (IA or IB) as the central metal
- B01J2531/16—Copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/10—Complexes comprising metals of Group I (IA or IB) as the central metal
- B01J2531/17—Silver
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/10—Complexes comprising metals of Group I (IA or IB) as the central metal
- B01J2531/18—Gold
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
- B01J2531/62—Chromium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
- B01J2531/64—Molybdenum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
- B01J2531/66—Tungsten
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
- B01J2531/72—Manganese
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
- B01J2531/74—Rhenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/825—Osmium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/828—Platinum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/842—Iron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/845—Cobalt
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/847—Nickel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A robust chelate complex is provided having formula (I) wherein M is a metal, preferably a transition metal; Z is an anionic donor atom, at least three of which are nitrogen, and the other is preferably nitrogen or oxygen; LI is a labile ligand; Ch,, Ch and Ch3, are oxidation resistant chelate groups which are the same or different and which form 5- or 6-membered rings -with the metal, and Ch^ is a chelate group having structure (a) wherein R, and R2_are the same or different and are preferably selected from the group consisting of hydrogen, halogen, methyl, and CF or when linked, a 5- or 6-membered ring cyclo substituent. The complex provides a stable, long-lived oxidation catalyst or catalyst activator.
Description
Title: LONG-LIVED HOMOGENOUS OXIDATION CATALYSTS
This work was supported by the National Institutes of Health, GM-44867 and the
National Science Foundation CHE9319505. The U.S. government may have rights in this invention.
BACKGROUND OF THE INVENTION Field of the Invention
This invention relates to metal chelate complexes for forming oxidation catalysts, and more particularly, to long-lived macrocyclic oxidation catalysts capable of catalyzing demanding oxidations with peroxidic and related primary oxidants.
Description of the Invention Background
While transition metal-based systems provide the major source of oxidants in both chemistry and biology, oxidation chemistry is much better developed in the latter area, i.e., many difficult selective oxidation reactions that are accomplished in biological processes have not been achieved in homogeneous synthetic systems. This difference is more glaring for oxidation chemistry than for any other major branch of reaction chemistry. Thus, compared with reduction chemistry or carbon20 carbon bond forming chemistry, oxidation chemistry is still severely limited in the number and quality of the available technologies for stoichiometric or catalytic processes.
The relative dearth of good homogeneous oxidation systems and catalysts is believed to be due to oxidative degradation. Complexes of high oxidation state middle and later transition metal ions, analogous to those that function as active intermediates in numerous enzymatic oxidations, have been difficult to attain synthetically because of the tendency of such complexes to quickly degrade their ligands.
In Collins, T.J., Designing Ligands for Oxidizing Complexes, Accounts
0 of Chemical Research, 279, Vol. 27, No. 9 (1994), synthetic metal-based oxidants are conceptually separated into two classes, metalloredox-active oxidants and metallotemplate oxidants. In metalloredox-active systems, the oxidizing moiety contains the metal ion which is in direct contact with the ligands. Consequently, these systems are limited by the small supply of ligands that are compatible with
5 oxidizing metal ions. Metallotemplate oxidants are not limited in such a way because the oxidizing entity is more remote from the metal ion, but
AP/P, 9 9/01455
ΑΡΟ ο (ι 9 1 9
- 2 metallotemplate systems are useful only for mild as opposed to rigorous oxidations that require highly reactive metalloxidants. The metal ion oxidants in oxygenase enzymes often catalyze rigorous oxidations such as the meihane monooxygenase reaction, i.e., the oxidation of methane to methanol with oxygen as the primary oxidant. The roles of the metallo-oxidants in such enzymes are of the metalloredo.x-active type. Thus, a key to moving this spectacular enzymatic chemistry into man-made systems lies in conquering the challenge of developing robust ligand systems that can tolerate extremely strongly oxidizing metal ions of the atom-abstractor type. . . <
In the Accounts article, Collins describes a design-oriented approach to formation of ligands and metal chelate complexes that are resistant to oxidative degradation. The Accounts article highlights a set of rules for attaining ligand systems that are inert to oxidative degradation. Several diamido-N-diphenoxido acyclic and tetraamido-N macrocyclic ligands, developed to be resistant to oxidative degradation, are also illustrated in the Accounts article, as arc middle and later transition metal complexes where the metal ions are in rare or unprecedented high oxidation states attainable by employing the macrocyclic ligands.
While being sufficient to allow preparation of the described rare high valent ions in stable form, including strong electron transfer oxidants, the set of rules of
0 the Accounts article is incomplete for achieving the goal of encapsulating an especially powerful metal-oxo oxidant similar to those found in monooxygenase enzymes such that the oxidant has a sufficient lifetime to-carry out bi-molecular oxidations. Attainment of such a goal had to wait to the developments in ligand design described herein.
AP/P/ 9 9/01455
AP000919
- 3 SUMMARY OF THE INVENTION The desired ligand and derivative complex stabilities are met by the macrocylic tetradentate ligand compound of the present invention. The compounds have the general formula,
wherein Rj and R2 are the same or different, linked or nonlinked, and each is selected from substituents that are unreactive, form strong bonds intramoiecularly with R, and R2 and with the cyclic carbon, are sterically hindered and are conformationally hindered such that oxidative degradation of a metal complex of the compound is restricted when the metal complex is in the presence of an
0 oxidizing medium. The hindrance prevents attainment of conformers that are conducive to intramolecular oxidative degradation.
Z is a donor atom, preferably an oxidation resistant metal-complexing atom, such as N or 0, bearing hydrogen where necessary;
X is a functional group, preferably an oxidation resistant functionality such as 0 or an NRS wherein Rs is methyl, phenyl, hydroxyl, oxy lie, -CFa or -CH2CF3;
R3 is a unit joining the adjacent Z atoms comprised of
SfiVtO/66 /d/dV
APO00919
- 4 &, is a unit joining the adjacent Z atoms comprised of
wherein and R7, Rs and R^, and R,o and R,,, Rl2 and Rj3, pairwise and cumulatively, are the same or different and each is selected from the group consisting of alkyl, aryl, halogens and CF3; and
R3 is a unit joining the adjacent Z atoms comprised of: (i)
wherein R,4 through R,7 are the same or different and each is alkyl, aryl, halogen, or CF3, and (ii) an aryl group including the mono-, di-, tri-, and tetra-substituted aryl and heteroaryl substituents
AP/P/ 9 9/01455 // w 'n n
ΑΡθ00919
- 5 wherein each Y may be any substituent or substituents, but preferably halogen, hydrogen, alkyl, aryl, amino, substituted amino, nitro, alkoxy, aryloxy and combinations thereof. The aryl group formulation replaces the four substituents, and the carbon atoms to which they are attached.
The present invention pertains to the novel changes to the macrocyclic structure that increase the robustness of tetra-aza macrocyclic ligands such that one can obtain ligand systems that can support catalysis based on purported highly reactive iftetal-oxo. intermediates similar to those of the monoxygenases. The degradation chemistry that required the described changes was completely unexpected. Most significantly, the new systems described herein support catalysis with highly desirable O-atom transfer oxidants, especially peroxides, making them available for a wide range of technological oxidation applications where there is significant promise of obtaining chemically- and cost-effective catalyses.
Transition metal complexes of macrocyclic ligands have been used to catalyze oxidations in the past. Patented systems include porphyrins and phthalocyanines, halogenated porphyrins and ligands related to porphyrins, and substituted tricycloazanonane and related macrocycles. All of these systems differ fundamentally from the system of the present invention in significant ways. First, the macrocylic tetraamides are tetraanionic and highly donating such that the
0 ligands of the present invention render accessible the reactive high valent states of metals much better than any of the other macrocycles employed. Second, the macrocycles of the present invention can attain a high degree of protection with or without recourse to halogen substituents - the nonhalogenated species have a higher degree of environmental friendliness. Third, complexes of the macrocyclic
5 tetraamides of the present invention exhibit a pronounced resistance to hydrolysis making them suitable for use in protic media, such as water, in which various metal ion salts are soluble. ί
The tetradentate macrocyclic compound of the present invention is designed to be complexed with a metal, preferably a transition metal, and most
0 preferably a transition metal selected from Group 6 (Cr group), 7 (Mn group), 8 (Fe group), 9 (Co group), 10 (Ni group) or 11 (Cu group) of the Periodic Table of / the Elements, to form the corresponding chelate complex.
AP/P/ 99/01455
APO 00 9 1 9
The invention therefore also includes a chelate complex of the formula
wherein M is a metal, Z is a donor atom, such as the oxidation resistant metal complexing atom described in the macrocyclic tetradentate compound of the invention above and Ch,, Ch2, Ch3 and Ch4 are oxidation resistant components of the chelate system which are the same or different and which each form five- to six-membered rings with the adjacent ZMZ atoms.
In the preferred embodiment, an axial ligand, L,, binds to the metal. L, is labile because it occupies its position relative to the metai until the chelate system is introduced into a solution containing an oxidant. The labile ligand will dissociate in solution and will be replaced by the oxidant, most generally an Oatom transfer agent, but also any general oxidant that can serve to activate the metal ion to perform catalysis. Preferred labile ligands include the Cl-anion, halide ions in general, CN', ROH, NH3, or any amine, carboxylate, phenol or phenoxide, nitrile, pyridine, ether, sulfoxide, ketone, or carbonate.
It has been determined that the oxidation site in iron complexes- of aromatic ring-containing macrocycles (one electron oxidized above the Fe'n state) can be manipulated by choice of the axial ligands as well as by the aromatic ring substituents. Strong s-donor anionic axial ligands (CN') favor a metal-centered oxidation i.e., Felv, whereas weaker donors (e.g., Clj favor a ligand-localized oxidation. The oxo intermediate form of the chelate complex system is believed to function as the actual catalyst in some applications. In others, the chelate system can be the sole site of oxidation, or the oxidation site can be mixed between the chelate system, the metal and any other ligand attached to the metal.
The chelate group’Ch, is preferably the constituent described above as Rs of the macrocyclic tetradentate compound. Ch2 and Ch3 correspond to the units R3
AP/P/ 9 9/01455
APο 0 Ο 9 1 9
- 7 and R4, respectively, of the macrocyclic tetradentate compound described above. Ch4 is preferably a linking constituent having the general formula
X='CC(R)2'C=X wherein (R)2 is equivalent to R, and R2 described above and X is the oxidation resistant functionality described above.
R, and R2 are key substituents in the design of the robust chelate complex and catalysts of the present invention. R, and R2 are preferably methyl, CF3, hydrogen or halogen, or may form, together with the carbon atom to which both are bound; a ring, such as a four-, five, or six-membered ring. It is believed that intramolecular reactions between the R, and R2 substituents in prior art complexes and an oxo ligand in a functioning catalytic system contribute to the rapiddegradation of the chelate ligand as has been heretofore experienced. See Fig. 1 for a proposed mechanism of oxidative degradation of the catalyst. It has been observed, for example, consistent with Fig. 1, that known catalyst compounds having diethyl substituents in the R,, R2 positions are sensitive to oxidative attack such that, while catalytic oxidations can be observed, the ligand system simultaneously undergoes slow oxidative degradation. All of the tetraamide macrocycles described in the Collins, Accounts of Chemical Research article cited above include the diethyl substituents in the R,, R2 positions. Thus, no macrocylic tetraamide ligand transition metal complex has been shown heretofore to be
0 competent to cany out useful oxidation catalyses by virtue of a significant longevity of the catalyst system.
DESCRIPTION OF THE FIGURES FIG. 1 is a schematic illustration of the proposed path of oxidative ligand
5 degradation of a catalyst system consisting of compound II and peroxides due to intramolecular reactions between a diethyl substituent and the oxo axial ligand;
FIG. 2 is an illustration of the manner in which conformational constraints prevent oxidative degradation of the oxo group;
FIGS. 3(a) and (b) are illustrations of two possible structures of the
0 macrocyclic tetraamide ligand of the present invention showing the arm, linker and bridge components of the compound;
FIG. 4 is a view of a recyclable metallo-oxidant system;
FIG. 5 is a schematic view of an amino pendant macrocycle metal complex covalently bound to a support surface; and 35 FIG. 6 is an illustration of several chelate complexes formed from the macrocyclic ligands of the invention.
AP/P/ 9 9 / 0 1 4 5 5
APO009 19
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The preferred embodiment of the tetradentate macrocyclic compound of the present invention follows:
R wherein: R! and R2 are the same or different and each is selected from the group of substituents that are unreactive, form strong bonds intramolecularly with R, and R, and with the cyclic carbon, are sterically hindered and are conformationally hindered such that oxidative degradation of a metal complex of the compound is restricted when the complex is in the presence of an oxidizing medium. The low conformational freedom of the species prevents attainment of conformers that are conducive to intramolecular oxidative degradation. Z is a donor atom, preferably an oxidation resistant metal complexing atom, and more preferably N or 0, bearing H where necessary. Preferably at least three Z's are Ν. X is a functional group, preferably an oxidation resistant functionality, and more preferably 0 or NRS wherein Rs is methyl, phenyl, hydroxyl, oxylic, -CF3 or-CH2CF3.
R^, R7, R10 and R,, are the same or different and each is selected from the group consisting of alkyl, aryl, halogens and CF3. Rs is a unit joining the adjacent Z atoms and is selected from the group consisting of: (i)
AP/P7 9 9/01455
and
Rl7
AP Ο Ο Ο 9 1 9
- 9 wherein RH through R,7 are the same or different and alkyl, aryl, hydrogen, halogen, CFj or combinations thereof, and (ii) an aryl group including
wherein Y is halogen, hydrogen, alkyl, aryl, amino, substituted amino, nitro, alkoxy, aryloxy and combinations thereof.
The compounds of the present invention form robust, long-lived oxidation catalysts and precatalysts. For the sake of convenience, and without limiting the scope of the invention, catalyst will be used herein to include precatalysts and actual catalyst complexes, where the latter is the species that carries out the oxidation. In many cases, the precise catalytic mechanism is not known and thus the precise role in any given oxidation reaction of the chelate system of the present
0 invention may not be known. As used herein, robust oxidation catalyst means that when the catalyst is added to a solvent in the presence of an oxidant, such as a peroxide, the half-life of the activated form of the metal complex is 30 seconds or more. The half-life is the time in which half of the metal complex decomposes or degrades. ',
5 Surprisingly, the design of one of the most preferred embodiments of the new robust compounds differs from the prior art compounds by only one constituent. By changing the R,, R2 diethyl substituents of the prior art tetraamido compounds to dimethyl substituents, the previously fragile, short-liyed chelate complexes are transformed unexpectedly into stable, long-lived complexes which
0 are very resistant to oxidative degradation. What appeared to be a minor change in the structure is in fact the key to a new class of robust long-lived oxidation catalysts. The C-H bond strength of the methyl substituent is about 3 Kcal.mol’1 greater than the C-H bond strength of the corresponding ethyl substituent. It has
AP/P/ 9 9/01455
AP 0 0 0 9 1 9
- 10 been determined that any Rb R2 substituents which are unreactive, or which form strong bonds with the cyclic carbon, or are sterically or conformational hindered, such that they are restricted from intramolecular reaction with the axial oxo ligand will also form the robust catalysts, or precatalysts of the invention.
The importance of the bond strength and/or conformational constraints can be seen from the following determinations.
In Order to-support oxidation catalysis, every component of the ligand system must be substantially resistant to oxidative degradation. The key to the stability of the R, and R2 groups has been determined by observation in a particularly informative case. As shown in Fig. 1, iron (III)'aqua complexes react with hydroperoxides to give a purported oxo complex which it has been shown exhibit catalytic properties for the oxidation of nitriles containing C-H bounds a to the cyano group. However, as catalysis proceeds the ligand system slowly decomposes and it is proposed that this degradation proceeds via abstraction of an
H-atom from a methylene group of an ethyl substituent in the R, position as is consistent with the structure of the hydantoin-ring containing degradation product, labeled III (Fig. 1). Molecular models reveal that a highly strained conformation of the Ch4-containing chelate ring is required to bring the abstractable H-atom close to the abstracting O-atom. Compound III has been unambiguously characterized by a variety of mass spectrometric, ’H and 13C NMR, IR, elemental analyses.
Simultaneously with the observed degradation, the system catalytically oxidizes the weakest C-H bond in a series of nitriles [(CH3)2CHCN, CH3CH2CN, CH3CN, CD3CN] which are employed as solvents. The products are mixtures of nitrile oxidation products. Thus, where t-butyl hydroperoxide is the primary oxidant, the
5 product mixture with (CH3)2CHCN as the substrate contains (CH3)2C(OH)CN, (CH3)2(CN)COOC(CH3)3, (CH3)2(CN)COOCH3j (CH3)2C=O, (CH3)3COH. It has f
also been shown that while this product mixture suggests a free radical autoxidation process where the role of the iron complex, II (Fig. 1), would be to initiate the process, free radical autoxidation cannot be the dominant mechanism.
0 Thus, when the oxidation is carried out under l8O2 (1 atm, > 98%) the yield of ISO2 labelled products is too low for the reaction mechanism to be consistent with a completely free radical autoxidation process. By replacement of CH3- for CH3CH2in the R, and R2 positions, the ligand degradation is dramatically suppressed such that nitrile oxidation alone dominates the oxidative reactivity. This inhibition of
5 ligand degradation by the CH3- for CH3CFI2- can be rationalized as resulting from the increased C-H bond strength of CH3- versus CH3C2-5 ca? kcal/mol'1, thereby
AP/P/ 9 9 / 0 1 4 5 5
AP Ο 0 Ο 9 1 9
- 11 slowing the rate of the H-atom abstraction by the oxo ligand by ca. three orders of magnitude. Since it is apparent that the abstraction is critical to the degradation, the orientation of the abstractable H-atom with respect to the oxo ligand is also critical as this orientation determines the distance of approach and abstraction reactions are exquisitely distance dependent. Molecular models reveal that if a cyclopentyl unit is employed to replace the ethyl groups of R, and R2, the methylenic C-H group equivalent to that abstracted from the ethyl C-H group cannot rehch the oxo ligand without considerably more ring-strain than that found in the ethyl case. Thus, the conformational constraint approach serves to.
o dramatically increase the resistance of a so-substituted chelate to oxidative degradation.
In the structure shown in Fig. 2, the oxo group and methylenic H are restricted from as close an approach as in the ethyl case because the methylene group of the cyclopentyl substituent cannot rotate freely to bring the two groups into as close a juxaposition.
The compounds of the present invention are macrocyclic, comprised of four anionic donor ligands which result in concert to form a substantially planar tetradentate platform which can be complexed with a metal and axial ligand to form the chelate/catalyst system of the present invention. The preferred design for
0 producing robust ligands is a macrocyclic tetraamido ligand having no hydrogens ct to N-amido donor groups. When coordinated with the metal ion, five- and sixmembered chelate rings are most stable. The substituents can vary considerably provided they meet the requirements described above. This is particularly critical for the R) and R2 substituents.
5 An azide based synthetic route to macrocyclic tetraamido ligands is described in Uffelman, E.S., Ph.D. Thesis, California Institute of Technology, (1992). Alternatively, and preferably, the compounds of the present invention can be synthesized by a new synthetic route.
The new synthesis method permits the synthesis of variants which cannot
0 be synthesized via the prior art azide based method. In varying the macrocycle, however, it is important to preserve the general framework of the cpmpound. The macrocycle will be made up of 5- and 6-membered rings, in a 5,5,5,6 pattern, a 5,6,5,6, pattern, a 5,6,6,6 pattern, or a 6,6,6,6 ring pattern discussed in more detail below.
The new synthetic method proceeds generally as shown in sequences 1 and below. Specific examples of the application of the new method to the synthesis
SSV10/66 /d/dV
ΑΡ ο ο Ο 9 1 9
- 12 of some particular macrocyclic tetraamides are shown in sequence 3. For convenience of classification herein, the starting materials that are composed of diamine functionalities are sometimes referred to as Bridges (B), the starting materials composed of diacid functionalities are sometimes referred to as Linkers (L), and the starting materials composed of amine/acid functionalities are sometimes referred to as Arms(A). See Figs. 3(a) and (b). The arms of the macrocyclic compound are far more robust than the linker and are resistant to degradative attacks.
NH·
A.
2\.
OH ^0
< 70C
Solvent χΝΗ ΝΗχ
Ύτ .NH HN.
• ·
A
OH OH Λ +
H/1* NH2 Diamine \_/ preferably aryl
A
OH OH A ca 60% yield MACROLINKER (A-L-A)
Solvent + coupling agent
ca 30% yield of Macrocycle based on aryl diamine (B-A-L-A)
APIPI 99/01455 .NH HN. r ·
OH OH Λ
NH2 Diamine
Solvent + coupling agent w
NH HN • · y^^NH Hrj^^c (B-A-L-A)
Sequence 1 is a generalized synthesis of macrocyclic tetraamides having a (B-A-LA-) configuration, from ot-amino carboxylic acids via the new synthetic method. A diamide dicarboxyl-containing intermediate, sometimes referred to herein by the short hand designation, macro linker intermediate or simply the intermediate
SUBSTITUTE SHEET (RULE 26)
APO 00 9 1 9
- 13 (A-L-A) is preformed without the use of protecting groups via a selective double coupling reaction wherein an α-amino carboxylic acid, the arms, A, and an activated malonic acid derivative, the linker, L, in solvent are heated to form the macro linker intermediate. The macro linker intermediate is then coupled to a diamine, the bridge, B, in another selective double coupling reaction that employs a solvent, a coupling agent and heat. The synthetic methodology is highly streamlined and tolerates a wide range of functional groups. A wide range of macrocyclic tetraamides bearing different electronic or steric substituents have been prepared in this manner in good yield.
H?N 2
RO
Cl
Solvent
Cl
Λ substituted < 70 C /?-amino carboxlic ester malonyl dihalide Ο Λ o
ΓΙ'
OR RO ri
NH HN
OH HO
NH HN
H2N [>
\
AP/P/ 9 9 / 0 1 4 5 5 ca. 90% yield of Protected MACROLINKER
Deprotection (A-L-A) seq, ca. 80-90% yield w
Λ-NH HN\
Solvent + Coupling Agent
Diamine, Preferably Aryl
«.WAX
SUBSTITUTE SHEET (RULE 26)
AP 0 0 0 9 1 9
- 14 Sequence 2 is a generalized synthesis of macrocyclic tetraamides having a (B-A-LA-) configuration, from β-amino carboxylic acids via a modified version of the basic, or primary, synthetic method. The basic same approach employed with ctamino carboxylic acid starting materials is applied to β-amino carboxylic acid starting materials. For some β-amino carboxylic acids, use of a protecting group may be desirable, as shown in Sequence 2. A macro linker intermediate (A-L-A) is preformed via a selective double coupling reaction wherein a protected β-amino carboxylic ester arm, A, and an activated malonic acid derivative linker, L, in solvent are heated to form the intermediate, which, after deprotection, can then be coupled to the diamine bridge, B, in another selective double coupling reaction to yield a wide variety of substituted macrocyclic tetraamides with an expanded ring size compared to those that have been prepared from α-amino carboxylic acids.
The macro linker intermediate (A-L-A) can be made on a large scale in batch or continuous processing via direct reaction of a substituted malonyl dihalide with a solution (preferably a pyridine solution) of an cc or β-amino carboxylic acid or ester. Many examples of the reaction proceed in good yield without protecting groups at temperatures preferably less than or equal to about 70°C. Some examples may require the use of protecting groups and these reactions generally proceed in good yield. The intermediate can be separated into batches and each
0 separate batch further reacted with a wide range of diamine bridging compounds having different steric or electronic substituents in the presence of a coupling agent. For the α-amino carboxylic acid case, the ring closing step proceeds for 48120 hours and is ideally substantially moisture free. See Sequence 3. A wide range of tetraamido macrocycles having finely tuned electronic properties can be
5 synthesized at a considerable cost savings over the prior art azide method.
AP/P/ 99/01455
APO00919
Sequence 3 is a specific example of the preparation of a macrocyclic 5 tetraamide having a (B-A-L-A-) configuration from α-amino carboxylic acid starting materials. An α-amino carboxylic acid is mixed with an activated malonate in pyridine at temperatures less than 70°C. After the selective double coupling reaction is complete, 72-144 hrs, the macro linker intermediate (A-L-A) is ί
isolated. In a second step a diamine, preferably an o-phenylene diamine, is added 10 to a pyridine solution of the macro linker intermediate in the presence of a coupling agent, preferably PC13 or pivaloyl chloride. The ring closure, a double coupling reaction, is allowed to proceed at reflux for 48-110 hrs, and then the,desired macrocyclic tetraamide is isolated in good yield.
The synthesis of oxidatively robust macrocyclic tetraamides requires that 15 all H atoms a to the donor atoms be replaced by more oxidatively robust groups such as alkyl, halo, aryl or heterocyclic substituents.
s S * I 0 / 6 6 /d/dV
SUBSTITUTE SHEET (RULE 26)
APO00919
Structure 1 shows the key intermediate in the production of'the catalyst of the present invention, an oxidatively robust macro linker (Arm-Linker-Arm). This molecule can be readily synthesized in one step without the use of protecting groups via the direct acylation of a-methylalanine with dimethyl malonyl dichloride.
In an alternative embodiment, the method of the invention uses protection/deprotection sequences to generate a protected form of the macro linker intermediate. Upon deprotection, the intermediate is coupled via the double coupling reaction described above to generate the tetraamido macrocycle.
Similarly, protection/deprotection sequences can be applied to substituents present on the bridging unit to expand the range of bridging substituents that can be utilized in the macrocyclization reaction.
Both embodiments of the method of the invention rely heavily on the amine and carboxylic acid based starting materials hereinafter listed in Table 1. Table 1 lists several forms of the starting materials in what is designated the parent,
5 protected/activated and hidden forms of the amine and carboxylic acid functionalities in a general sense. Table 2 utilizes these categories in conjunction with chelation ring size constraints (5- and 6- membered chelate rings are preferred) in order to identify useful starting materials for the synthesis of chelating macrocyclic tetraamide compounds having the desired five- or six-membered ring.
As used herein parent groups (shown in italics in Table 1) define a preferred synthetic functionality. Protected/activated groups refers to those groups that contain an easily recognizable portion of the parent group. Hidden groups as used herein refers to those groups that need not contain an easily recognizable portion of the parent group but which are capable of ready conversion
5 to the parent group or to a protected/activated form of the parent group. More detailed examples may readily be found in Greene and Greene, Protective Groups
AP/F/ 9 9/01455
APO 0 0 9 1 9
- 17 in Organic Synthesis, John Wiley and Sons, New York (1981). An extensive lisr of protecting/activating groups particularly suitable for peptide synthesis may be found in G. A. Fletcher and J. H. Jones, A List of Amino-Acid Derivatives Which are Useful in Peptide Synthesis, Int. J. Peptide Protein Res. 4, (1972), p.347-371.
Table 1
Protected/
Activated
Amines
Hidden Protected/ _ Hidden
Activated
Amines Carboxylic Acids
Carboxylic Acids
N-alkyl amines | azides | activated esters | nitriles |
amides | azo compounds | acyl halides | oxazolines |
amino acetals | imides | amides | L |
N-benzyls | isocyanates | anhydrides | L * |
carbamates | isothiocyanates | hydrazides | 4 |
enamines | nitrilium ions | O-acyl oximes | |
hydrazines | nitro compounds | oxazolidines | ( < |
imines | phosphazos | oxazalones | |
N-oxides | phosphite esters | 1 | |
N-phosphinyls | silyl esters | 1 | |
N-phosphoryls | stannyl esters | ||
N-Metal derivatives | substituted benzyl esters ί | ||
silyl amines (N-Si) | substituted ethyl esters | ||
N-Sulfenyls | substituted methyl esters | ||
sulfonamides | sulfonyl esters | ||
N-Sulfonyls | / sulfenyl esters | ||
urea derivatives |
AP/P/ 9 9 / 0 1 4 5 5
ΑΓ Ο ύ Ο 9 1 β
- 18 Structure 2 is used herein to define the short hand notation shown in Table 2 and Table 3 that specifies the chelate ring sizes (including the metal ion) that are formed when a given macrocyclic ligand is coordinated to a transition metal center.
Structure 2
Amine is designated by a, and carboxylate'by c.
Dashes (-) indicate amide bonds. Every dash must connect a trailing a to a leading c or vice versa, the final dash wraps around to the beginning. Structure 2 illustrates a (5,5,6,5) macrocyclic ligand shown in metal coordinated form with chelate ring sizes (including the metal ion) indicated. Using a counterclockwise rotation, the specific macrocycle employed is 5aa-5ca-6cc-5ac- (or any cyclic permutation thereof).
The parent (=) forms of the functional groups for each starting material are shown pictorially in Table 2 below, while possible combinations of protected/activated (p/a) or hidden (h) forms for each starting material are shown in tabular form. Variable positions are marked with a bullet (·). The underlined side captions are in a shorthand notation that refers to chelation ring sizes formed when the particular starting material is incorporated into a macrocycle and coordinated to a metal center. (See Structure 2)
AP/P/ 99/01455
SUBSTITUTE SHEET (RULE 26)
AP0U0919
- 19 Table 2
5ac
HO NH2 — 1 2
ΛΛ h2n nh2
C, 2-N | C, 2-N | A | 2-N |
— | p/a = | h | = |
= p/a | _ p/a p/a | h | p/a |
= h | p/a h | h | h |
C, 2-N | C, 2-N | Ci | 2-N |
p/a = | h | ||
= p/a | p/a p/a | h | p/a |
= h | p/a h | h | h |
C, C, | c, c3 | Ci | C3 |
= = | P = | h | |
= p/a | p/a p/a | h | p/a |
= h | p/a h | h | h |
C, 3-N | Ci 3-N | Cl | 3-N |
= = | p/a = | h | = |
= p/a | p/a p/a | . h | p/a |
= h | p/a h | h | h |
1-N 3-N | 1-N 3-N | 1-N 3-N |
II II II »-9 11 P | p/a = p/a p/a p/a h | h = h p/a h h |
The complete range of macrocyclic tetraamide compounds able to be synthesized from the starting materials identified in Table 2 is shown in general terms in Table 3. Each unique combination has been listed pictorially and labelled with the shorthand notation of Structure 2 defined above.
Table 3
AP/P/ 9 9/01455 membered tetraamide macrocycle (5,5,5.6)
5ac-5aa-5ca-6ccSUBSTITUTE SHEET (RULE 26)
ΑΡ ο ο ο 9 ι 9
- 20 14 membered tetraamide (5,5,6,6) and (5,6,6,6) 0°Ύ*^γίίNH ΗΝ—# NH ΗΝ. ·—NH ΗΝ ( J C j C X
NH ΗΝ—· · ^ΝΗ HIT 4-K,u UKI^
NH HN .NH HN-
Ο' o
5aa-5cc-6aa-6cc- 5aa-6cc-5aa-6ccNH ΗΝ-
5aa-5ca-6ca-6cc5aa-5ca-6cc-6ac-
5aa-6cc-5ac-6ac5ca-6cc-5ac-6aa5ca-5ca-6cc-6aa15 membered tetraamide macrocycles (5.6,6.6)
5aa-6cc-6aa-6cc- 5aa-6ca-6cc-6ac-
AP/P/ 99/01455 °γγ°
5ca-6cc-6ac-6aaSUBSTITUTE SHEET (RULE 25)
AP 0 ύ Ο 9 1 9
The individual Bridge, Arm and Linker starting materials can either be obtained commercially or synthesized by standard techniques. Examples of syntheses for a few noncommercially available starting materials are provided herein and in the Experimental Section. A powerful alternative route for the preparation of substituted and unsubstituted malonates has been reported by A. P. Krapcho, E. G. E. Jahngen, Jr. and D. S. Kashdan. α-carbalkoxylations of carboxylic acids. A general synthetic route to monoesters of malonic acids, Tet.
Lett. 32, p. 2721-2723 (1974). The oxidatively robust macrocyclic tetraamides shown in Table 3 may be used to synthesized without having to resort to the use of species that contain high energy N-N bonds, such as axides, hydrazines and azo constituents.
Schematics 1 to 3 below pictorially demonstrate substitution at the variable positions shown by a ·· in Table 3. The remainder of this section discusses how to choose R substituents in general terms, and lists some representative examples of substituted Bridge, Arm and Linker starting materials in tabular form.
Single Node Substitution !
Starting materials containing only one variable position are substituted by a
0 carbon atom bearing two R groups, a -C(Ra)(Rb)- unit, (in this context the dashes (-) refer to single bonds as opposed to amide bonds).
AP/P/ 9 9 / u 1 4 5 5
SUBSTITUTE SHEET (RULE 26)
APO 00 9t 9
T
HO θΗ
NHi
KO
substituted malonic aci.as a-amino carboxylic acids
Schematic 1: Replacement of a single variable position is always by a -C(RJ(Rb)unit.
For substitution at any single variable position the R groups on the C(Ra)(Rb)- unit may be the same or different and are selected from the group consisting of hydrocarbons and heteroatom (e.g., halogen, N, O, Si, P, S) substituted hydrocarbons. Specific choices for the R groups other than R, and R2 are from the following types/subtypes either singly or in combination (e.g. for R = arylsilylester, only aryl, esters and siloxanes are listed); H, ketones, aldehydes, carboxylic acids, hidden or protected/activated carboxylic acids (see Table 1), esters, ethers, amines, hidden or protected/activated amines (see Table 1), imines, amides, nitro, sulphonyls, sulfates, phosphoryls, phosphates, silyl, siloxanes, alkyl, alkenyl, alkynyl, halo, aryl, and compounds chosen from biological systems e.g.
natural or unnatural amino acid sidechains, heterocyclic rings, lactams, lactones, alkaloids, terpenes (steroids, isoprenoids), lipid or phospholipid chains.
For single node substitution, fusion of the Ra and Rb groups at a position that is not the site of substitution, but a to the site of substitution yields.;a species doubly bonded to the node such as an oxo (=0), imine (=NRa), or a substituted vinyl group (=CRaRb). Formation of imines or substituted vinyl groups constitutes a form of nodal migration. If the original Ra and Rb groups are fused at a site that is not the site of substitution and is not a to the site of substitution then a cyclic ring structure is formed. If such cyclic groups are formed, additional R substituents on the cyclic groups are chosen in the same manner as for normal
0 single node or multi node substitution (including the possibility of further R group fusions at one or more nodes to yield additional oxo, imine, substituted vinyl groups, or spiro, benzo, substituted benzo, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, cycloalkenyl or substituted cycloalkenyl ring
AP/P/ 9 9 / 0 1 4 5 5
AP O 0 0 919
- 23 structures). Preferred spiro/cyclic ring sizes are four-, five- or six- membered rings.
Multi Node Substitution
“Ά
h2N nh2
1,2-alky I diamines
1,2-aryl diamines
AP/P/ 9 9/01455
Schematic 2: Replacement at two variable positions can be by two -C(Ra)(Rb)units or the two variable positions can be combined to make up part of an aryl or
J heterocyclic ring structure.
For multiple node substitution individual -C(RJ(Rb)- positions are substituted identically as for single node substitution (see above). In addition to the types of substitution found for single nodes, it is also possible to combine or connect multiple nodes together via fusion of the R groups located on different nodes at sites that either are (combination), or are not (connection), the sites of
SUBSTITUTE SHEET (RULE 26)
AP000919
- 24 attachment. Combination of sites that are adjacent leads to ethylenic units (C(Rj)=C(Rh)-) a form of R group elimination. Connection of nodes via R group fusion at sites that are not the points of attachment or combination of sites that are not adjacent leads to the formation of cyclic structures, such as spiro, benzo, substituted benzo, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, cycloalkenyl or substituted cycloalkenyl ring structures. Five- and sixmembered rings.are preferred.
If cyclic groups are formed, or if there are residual R groups remaining from combination at adjacent sites, the residual R groups and the substituents on the cyclic groups are chosen in the same manner as for normal single node or multi node substitution (including the possibility of further R group fusions to'yteld additional spiro, benzo, substituted benzo, heterocyclic, substituted heterocyclic, cycloalkyl, substituted cycloalkyl, cycloalkenyl or substituted cycloalkenyl ring structures).
An important point is that the definitions for both single node and multi node substitution can function recursively, e.g. substituted o-phenylene diamine => substituted heterocyclic o-phenylene diamine => substituted spiro-cycloalkyl heterocyclic o-phenylene diamine etc.
nh2 nh2 substituted n,n+2-diamine alkanes
NH,
NH2
substituted o-amino benzylamines
substituted
1,8-diamino napthalenes
AP/P/9 9 /91455
SUBSTITUTE SHEET (RULE 26)
AF ΰ q ο 9 ί 9
-25Schematic 3: Replacement at three variable positions can either be by three C(Ra)(Rb)- units or two of the variable positions can be combined to make up part of an aryl or heterocyclic ring structure with the third position being replaced by a C(Ra)(Rb)- unit or the three variable positions can all be combined to form part, of a fused diaryl, fused aryl heterocyclic, or fused diheterocyclic ring structure.
Some representative examples of commercially available and/or synthetically versatile Linker, Arm and Bridge starting materials are shown ifl Tables 4, 5 and 6, respectively. A macrocyclic tetraamido compound having the desired chelate ring configuration shown in Table 3, i.e., 5556, 5566, 5656, 5666 or 6666, and variations thereof, can be constructed by reference to the general choice and combination of starting materials for various chelate configurations shown in Table 2, i.e., parent, protected/activated or hidden, followed by the choice of the specific starting materials from Tables 4, 5 and 6. Use of those functionally and similar starting materials in the new synthetic method will provide a macrocyclic tetraamido compound having a chelate ring configuration and substituent array suited to a particular end use. The symbol * in the Tables indicates a substituent that is comparatively robust towards oxidation. The symbol f in the Tables indicates substituents that are very oxidatively robust.
Table 4 identifies some representative dicarboxylic acid malonate derivatives, i.e. Linkers, of interest for the preparation of macrocyclic tetraamides, ί
either in parent, hidden, or protected/activated forms. ,
AP/P/ 9 9/01455
SUBSTITUTE SHEET (RULE 26)
APO JO 9 1 9
-26Table 4 - The Malonates Derivatives of Oxalic Acid (5cc)
Registry # Compound Name ’Oxalyl Chloride
Derivatives of Malonic Acid (6cc)
Registry # Compound Name Registry # Compound Name
Disubstituted malonates | |
31696-00-1 ’Diethyl butyl ethyl- | ’Diethyl di-n-octyl- |
malonate | malonate |
00596-76-9 ’Diethyl butylhexyl- 24251-93-2 | ’Diethyl di-n-pentyl- |
malonate | malonate |
00083-27-2 ’Diethyl butylmethyl- | ’Diethyl di-2-propenyl- |
malonate | malonate |
’Diethyl butylethyl- 03195-24-2 | ’Diethyl di-n-propyl- |
malonate | malonate |
’Diethyl butylpentyl- | ’Diethyl ethylheptyl- |
malonate | malonate |
‘Diethyl butylpropyl- | ’Diethyl ethylhexyl- |
malonate | malonate |
*2,2-Diethyl-butyric acid 00133-13-1 | ’Diethyl ethyl (1-methyl butyl) malonate ( |
18719-43-2 ’Diethyl 1,1-cyclo-butane | ’Diethyl ethyhnethyl- |
dicarboxylate | malonate |
53608-93-8 ’Diethyl 1,1-cyclo-propane 02049-70-9 | ’Diethyl ethyl (1-methyl- |
dicarboxylate | propyl) malonate |
01559-02-0 ’Diethyl decylethyl- | ’Diethyl ethylnonyl- |
malonate | malonate |
AP/F/ 9 9/01455
SUBSTITUTE SHEET (RULE 26)
AP 0 ii ϋ 9 1 #
-26/1-
05077-96-3 | ’Diethyl decylmethyl- malonate ’Diethyl dially 1- malonate | 05408-35-5 00076-67-5 | ’Diethyl ethyloctyl-malonate ’Diethyl ethylpentyl-malonate |
00597-55-7 | ’Diethyl, di-n-butyl- | ’Diethyl ethylphenyl-malonate | |
malonate | |||
00596-75-8 | ’Diethyl di-n-decyl- | 71691-56-0 | ’Diethyl ethylpropyl-malonate |
malonate | |||
’Diethyl diethyl- | *Diethylmethyl(2-methyl- | ||
malonate | butyl) malonate | ||
’Diethyl di-n-heptyl- | ’Diethyl methyl(2-methyl- | ||
malonate | propyl) malonate | ||
’Diethyl di-n-hexyl- | 34009-61-5 | ’Diethyl methylnonyl-malonate | |
malonate | |||
^Diethyl dimethyl- | 01575-67-3 | tDiethyl methylphenyl- | |
malonate | malonate | ||
01619-62-1 | ’Diethyl di-n-nonyl- | 58447-69-1 | ’Diethyl methylpropyl- |
malonate | malonate | ||
*1,1-cyclopropane | 00083-27-2 | ’Diethyl methyl-iso- | |
dicarboxylate | propylmalonate | ||
*1,1-cyclopentane | *1,1-cyclobutane | ||
dicarboxylate | dicarboxylate t | ||
^ditri fluoromethyl | *1,1-cyclohexane | ||
malonic acid | dicarboxylate | ||
idifluoro malonic acid | Mitrifluoroethyl malonic acid } | ||
^dichloro malonic acid |
Table 5 identifies some representative a and β-amino carboxylic acids, i.e. Arms, of interest for the preparation of macrocyclic tetraamides, either in parent, hidden, or protected/activated form.
AP/P/ 9 9 / 0 1 4 5 5
SUBSTITUTE SHEET (RULE 26)
ΑΡΟ00918
- 27 Table 5 - The Amino Carboxylic Acids
Derivatives of α-Amino Carboxylic Acids (5ac) ’R(-)-2-amino-2-methyl butanedioic acid ’S(+)-2-amino-2-methyl butanedioic acid *S(+)-2-am.ino-2-methyl butanoic acid hydrate c ’2-amino-2-methyl butyric acid ’2-amino-2-methyl glutaric acid ' R(-)-2- amino-2-methyl -3 -hydroxy propanoic acid ’S(+)-2-amino-2-methyl-3 -hydroxy propanoic acid *(S)-2-amino-2-methyl-4phosphonobutanoic acid ^cqcx-diphenyl glycine ^-amino-isobutyric acid (a-methyl alanine) ’cis-1 -amino-3-(2-phosphonoacetyl) cyclobutane-1-carboxylic acid *S(-)-2-amino-2-methyl-4-pentenoic acid monohydrate *2-amino-2-norbomane carboxylic acid *R(-)-2-amino-2-phenylbutyric acid * 1 -aminocyclopropane-1 -carboxylic acid ’ 1 -aminocyclobutane-J -carboxylic acid ’ I -aminocyclopentane-1 -carboxylic acid (cycloleucine) ’ 1 -aminocyclohexane-1 -carboxylic acid 'S(+)-2-amino-2-methyl-3 -phenyl propanoic acid ta-phenyl alanine ((+/-)a-methyl-a-phenvl glycine) ’S(+)-2-amino-2-phenylbutyric acid
Derivatives of β Carboxylic Acids (6ac) *+The β-amino acids derived from 2-amino-benzoic acid (anthranilic acid) are quite oxidatively robust
AP/P/ 9 9/01455
Registry # | Compound containing 2-amino-benzoic acid | Registry # | Compound containing 2-amino-benzoic acid |
118-92-3 | ^o-amino-benzoic acid, anthranilic acid) | 118-92-3 | +(o-amino-benzoic acid, anthranilic acid) |
619-17-0 | T4-nitro- | 3177-80-8 | '3-methoxy- |
616-79-5 | ^-nitro- | 6705-03-9 | ’5-methoxy- |
4389-45-1 | *3-methyl- | 394-31-0 | ’5-hydroxy- |
2305-36-4 | ’4-methyI- | 4920-81-4 | ’3-hydroxyhydrochloride |
2941-78-8 | ’5-methyl- | 446-32-2 | 14-fluoro- |
APO 00 9 19
4389T50-8 | ‘6-methyl- | 446-08-2 | T5-fluoro- |
609-86-9 | 's,5-diiodo- | 434-76-4 | 16-fluoro- |
5653-40-7 | '4,5-dimethoxy- | *4-chloro-5-sulfamoyl- | |
50419-58-4 | '3,4-dimethyl- | 6388-47-2 | U-chloro- |
14438-32-5 | '3,5-dimethyl- | 89-77-0 | T-chloro- |
15540-91-7 | ’3,6-dimethyl- | 635-21-2 | *5-chloro- . |
2789-92-6 | ^.S-dichloro- | 2148-56-3 | ^-chloro- |
609-85-8 | *3,5-dibromo- | ’3-bromo-5-methyl- | |
’3,5-dibromo-6-fluoro- | 1765-42-0. | *3,4,5,6Tgtrafluro- | |
61948-85-4 | *3,4,5-trimethoxy- |
Registry # | Other β-amino carboxylic acids | Registry # | Other β-amino carboxylic acids |
5959-52-4 | +3-amino-2-napthoic acid | ||
5434-20-8 | '3-amino-pthalic acid | 5345-47-1 | '2-amino-nicotinic acid (2-aminopyridine-3carboxylic acid) |
614-19-7 | ’β-amino-hydrocinnamic acid (D,L-3 -amino-3 -phenylpropionic acid) | 82-24-6 | T-aminoanthraquinone-2- carboxylic acid |
52834-01-2 | ’2-amino-4,6-dimethyl-3pyridinecarboxylic acid hydrochloride | 1664-54-6 | *3-amino-3 -phenylpropionic acid |
54711-21-6 | '5-amino-4-cyano-l -methylpyrazole | 50427-77-5 | ‘5-amino-l- phenylpyrazole-4- carboxamide |
698-29-3 | '4-amino-5-cyano-2-methyl pyrimidine | 72-40-2 | ’5(4)-aminoimidazole- 4(5)-carboxamide hydrochloride |
’4-amino-5-cyano-2-methoxy pyrimidine | 68302-09-0 | ’2-amino-7-ethyl-5-oxo5 H-[ 1 ]benzopyrano [2,3 b]pyridine-3 -carboni t rile | |
41680-34-6 | *3-aminopyrazole-4carboxylic acid | 22603-53-8 | ’2-amino-3,5- dinitrobenzonitrile |
87550-19-4 | *3,6-dinitrophthalic acid pyridine salt | . *5-amino-4-cyano-l-(4- chlorophenyl)pyrazole | |
5424-01-1 | *3-amino pyrazine-2carboxylic acid | ’ 5-amino-4-cyano-l -(4nitrophenyl)pyrazole |
fiSVVO/66 /d/dV
ΑΓΟ 9 0 919
- 29 10312-55-7 '2-amino terepthalic acid
16617-46-2 ’5-amino-4-cyano pyrazole
6375-47-9 ’3-amino-4-acetamido anisole
Table 6 identifies some representative diamines, i.e. Bridges, of interest for the preparation · of macrocyclic tetraamides, either in parent, hidden, or protected?activated forms. Amine and protected/activated or hidden amine functionalities are used interchangeably.
Table 6 - The Diamines . ' ~ ~
Derivatives of 1.2-Aryl Diamines (5aa) 'UH of the aryl diamines shown are comparatively robust towards oxidation.
Registry # Compound containing Compound containing o-Phenylenediamine Registry # o-Phenylenediamine
95-54-5 | Substituents = 0 f( 1,2-Benzenedi amine) | 95-54-5 | Substituents = 0 ^l^-Benzenediamine) |
18645-88-0 | No. of Unique Substituents = 1 t3-fluoro- | 21745-41-5 | No. of Unique Substituents = 1 ^-chloro- |
367-31-7 | M-fluoro- | 95-83-0 | M-chloro- |
153505-39-6 | t3,4-difluoro- | 1668-01-5 | t3,4-dichloro- |
2369-29-1 | ^^-difluoro- | 5233-04-5 | ^-dichloro- |
2369-30-4 | ^.e-difluoro- | 21732-93-4 | t3,6-dichloro- |
76179-40-3 | M^-difluoro- | 5348-42-5 | j4,'5-dichloro- |
168966-54-9 | +3,4,5-trifluoro- | 30064-28-9 | +3,4,5-trichloro- |
363-74-6 | +3,4,6-ϊπΑπογο- | 1962-10-3 | / ^A^-trichloro- |
2993-07-9 | t3,4,5,6-tetrafluoro- | 877-12-3 | t3,4,5,6-tetrachloro- |
1575-36-6 | ’3-bromo- | 34446-43-0 | *3-iodo- |
1575-37-7 | ’4-bromo- | 21304-38-1 | ’4-iodo- |
1575-38-8 | *3,5-dibromo- | 144793-03-3 | ’3,6-diiodo- |
AP/P/ 9 9 / 0 1 4 5 5
AP Ο Ο Ο 9 1 9
69272-50-0 | *3,6-dibromo- | 76179-43-6 | ’4,5-diiodo- |
49764-63-8 | ’4,5-dibromo- | ||
No. of Unique Substituents = 2 | No. of Unique Substituents = 2 | ||
75293-95-7 | ''4rbromo-5-chloro- | 132915-81-2 | ^-chloro^-fluoro- |
16429-44-0 | *5-bromo-3-chloro- | 153505-33-0 | ^-chloro-S-fluoro- |
172215-94-0 | ‘3-bromo-4,5-dichloiO- | 139512-70-2 | U-chloro-5-fluoro- |
98138-54-6 | ’4-bromor3,5-dichloro- | 153505-43-2 | ’5-chloro-3-iodo- |
74908-80-8 | ’3,5-dibromo-4-chloro- | 153505-34-1 | ^-chloro^S-difluoro· |
115440-10-3 | ‘3-bromo-5-fluoro- | 170098-84-7 | M-chloro-S^-difluoro· |
153505-37-4 | ’4-bromo-5-fluoro- | 156425-14-8 | +4-chloro-3,5,6- trifluoro- |
153505-35-2 | ’ 3-bromo-4,5 -difluoro- | 153505-47-6 | ’4,5-dichloro-3-iodo- |
156425-12-6 | ‘4-bromo-3,5.6-trifluoro- | 18225-92-8 | 73,4,6αγϊοΜογο-5- |
153505-45-4 fluoro*5-fluoro-3-iodoAP/P/ 9 9 / 0 1 4 5 5
Registry Number | Additional 1,2-Benzenediamines | Registry Number | Additional 1,2H3enzenediamines t |
’4,5-dimethyl- | *4-methyl- | ||
t4,5-dinitro- | +4-nitro- | ||
88580-71-6 | ’4,5-dimethoxy- | *4-methoxy- | |
’4,5-diamino- | ’4-amino- | ||
+4,5-diacetamido- | U-acetamido- | ||
t4,5-ditrifluoroniethyl- | +4-trifluoromethyl- | ||
+4,5-dicyano- | +4-cyano- | ||
*4,5-dihydroxy | 615-72-5 | 4-hydroxy (3,4- diamino-phcnol) |
APO 7 0 9 1 9
59649-56-8 | ’3-hydroxy (2,3diamino-phenol) | ||
Other n,n+l-Diamines | Other n,n+l -Diamines | ||
tl,l,2,2-tetramethyl ethylene diamine | 452-58-4 | ’2,3-diamino pyridine | |
7598-26-7 | *2-amino-3-nitro-5-methyl •pyridine | 54-96-6 | '3,4-diamino pyridine |
6635-86-5 | '2-amino-3-nitro-4-picoline (2-amino-4-methyl-3-nitro pyridine) | ’2-amino-3-nitro-5- bromo-pyridine | |
82039-90-5 | *5-amino-4-nitro-imidazole | ‘4-amino-5-nitro-6- chlor-pyrimidine | |
*5-amino-3-methyl-4-nitro- isoxazole | ’2-amino-3-nitro-9- fluorenone | ||
’5-amino-1,3-dimethyl-4nitro-pyrazole | 7598-26-7 | '2-amino-3-nitro-5- methyl-pyridine | |
6632-68-4 | ’6-amino-l ,3-dimethyl-5 nitroso-uracil | *4-amino-5-nitroso- uracil | |
22603-53-8 | ’2-amino-3,5-dinitro- benzonitrile | 1672-48-6 | ’6-amino-5-nitroso-2- thio-uracil |
3531-19-9 | ’ 1 -amino-2,4-dinitro-6chlorobenzene | *2-amino-5-bromo-3- nitro-pyridine | |
5442-24-0 | ’4-amino-2,6-dihydroxy-5- nitro-pyrimidine | 33685-60-8 | +9,10-dinitro-anthracene |
’4-amino-2,6-diketo-1,3dimethyl-5-nitroso-pyrimidine | *6,7-dinitro-2,3- diphenoxy-quinoxaline | ||
’ 1,2-dinitro-tetramethylbenzene | 35975-00-9 | f5-amino-6-nitro- quinoline | |
’cis-1,2-diamino-1,2dimethyl-cyclohexane | 771-97-1 | ^J-diamino-napthalene ί | |
*cis-l,2-diamino-l,2- dimethyl-cyclopentane | 938-25-0 | H^-diamino-napthalene | |
36023-58-2 | ^^-diamino^J-dicyano- pyrazine | 39070-63-8 | ‘3,4-diamino- benzophenone |
5440-00-6 | ’5,6-diamino-l ,3-dimethyluracil | 68836-13-5 | T6,7-dinitro-quinoxaline |
’5,6-diamino-3-methyl-uracil | '5,6-dinitro-quinoxaline- 2,3-dione | ||
1758-68-5 | +1,2-diaminoanthraquinone | 2379-57-9 | ’6,7-dinitro-quinoxaline- 2,3-dione |
AP/P/ 9 9 / 0 1 4 5 5
AF Ο 0 0 9 1 9
- 32 6968-22-5
13754-19-3
3240-72-0 *3-amino-4-nitro-benzoic acid 52057-97-3
U.S-diamino-pyrimidine 1672-50-0 *4,5-diamino-uracil (5,6diamino-uracil) ’3,4-diamino-5-hydroxypyrazole sulfate ’4,5-diamino-6-hydroxypyrimidine
Derivatives of n,n+2 Diamines (6aa)
Registry # n,n+2-diamines *2-amino-2-(2-aminophenyl)propane
T,3-diamino-l,3dimethylcyclohexane
479-27-6 tl,8-diaminonapthalene
Registry # n,n+2-diamines ^Adiamino^A dimethyl-pcntane-3-one ’2,4-diamino-2,4dimethyl-pentane
The list of n, n+2-Diamines is significantly shorter than for the other derivatives, in large part because the syntheses of the required n,n+2 diamines are more complex than for the n, n+1 diamines.
Some specific examples of bridge, arm and linker starting materials are 10 shown in Table 7. In each case the amide bonds have been retrosynthetically decomposed to form an amine equivalent (amine, nitro, azide, isocyanate, etc. see Table 1) and a carboxylic acid equivalent (acid, ester, acyl chloride,(nitrile etc. see Table 1). t
The bridges and linkers of Table 7 conserve local two fold symmetry while 15 all of the arms shown lead to 5-membered chelate rings.
AP/P/ 9 9 / 0 1 4 5 5
ΑΓ U υ 9 1 9
Some specific Bridge, B, Arm, A, and Linker, L, starting materials.
The R groups do not participate in the synthesis reaction so numerous 5 variations are possible. However, as discussed above, to form the oxidatively robust compound and catalyst, there are certain restrictions placed on the R groups. There is considerable evidence that hydrogen atom abstraction occurs between the linker's R substituents and the axial ligand bound to the central metal atom of the ultimate chelate system. This abstraction then is believed to lead to oxidative degradation, as shown in the proposed mechanism of Fig. 1. Molecular models revealed that, in a boat conformation of the macrocyclic complex's six-membered linker ring, the methylene H-atoms of the ethyl groups can reach to the oxygen atom of an Fe-oxo complex. This and other data lend support to the mechanism shown in Fig. 1 and explain the parameters of the R, and R2 substituents. To avoid the H-atom abstraction and consequent degradation, the R groups of the preferred macrocyclic compounds should be those that will slow down the H-atom abstraction reaction and thereby slow down oxidative degradations To accomplish this, the R, and R2 groups of the compound of the present invention are those that have a good bond strength, are unreactive, or which are not accessible to the axial ligand, such as sterically or conformationally hindered groups. Any one or any combination of these attributes may be employed. The latter option can be achieved by reducing the conformational freedom of the R, and R2 groups so that
AP/P/ 9 9 / 0 1 4 5 5
SUBSTITUTE SHEET (RULE 26)
ΑΤΟ 00 9 1 8
- 34 they simply are not close enough to react. As used herein good C-H bond strength means more than 94 Kcal.mol'1 or more than 85 Kcal.mol·’ for sterically inaccessible C-H bonds.
The malonate linker portion is the most sensitive part of the macrocycle 5 ligand. Preferred R groups on the linker include methyl, halogen, hydrogen, CF3 and a spiro-cyclopentyl or spiro-cyclohexyl ring in place of R, and R2.
There is considerably more freedom in choosing the R substituents for the arm portions than for the linker because of the robustness of this portion of the compound which may reflect the inability of a five-membered ring to adjust to 10 bring oxidizable C-H groups in contact with an axial oxo ligand. Thus, the'R groups of the a and β-amino carboxylic acid can also be chosen to tailor the substituents of the resulting macrocycle to the desired end use. The macrocycle may be symmetrical or asymmetrical. For asymmetrical macrocycles, two different amino acid starting materials are used and the resulting macrocycles are a 15 mixture of symmetrical and asymmetrical versions. The two versions can be separated by known separation techniques the present invention are shown below.
A few examples of the compounds of
5*10/66 /d/dV ci ci
Once the macrocyclic tetradentate ligand has been prepared, the macrocyclic compound may be complexed with a wide range of metal ions, preferably a transition metal, and most preferably a transition metal selected from
SUBSTITUTE SHEET (RULE 26)
ΑΡ ϋ j υ 9 1 9
- 35 Group 6, 7, 8, 9, 10 or 11 of the Periodic table of the Elements, to form a chelate complex of the formula
wherein M is the metal, Z is an oxidation resistant metal-complexing atom, such as N or 0, L, is any labile ligand, Ch,, Ch2, Ch3 and Ch4 are oxidation resistant components of the chelate system described above which are the same or different and which form five- or six-membered rings with the adjacent ZMZ atoms.
Complexation is achieved by the following method. The macrocyclic ligand is dissolved in a supporting solvent, usually THF, and deprotonated by treatment with a base, preferably lithium bis-trimethylsilylamide, lithium di20 isopropyl amide, t-butyl lithium, n-butyl lithium, or phenyl lithium. Any base that removes the protons at the metal complexing site, i, e., the amide N-H protons of a tetraamido compound, will suffice. Noncoordinating organic soluble bases are preferred. After the ligand is deprotonated, a meta] ion is added. The resulting intermediate, a comparatively low valent ligand metal species, is then oxidized.
5 The oxidation step is preferably performed with air, chlorine, bromine, or benzoyl peroxide to produce the metal chelate complex usually as a'lithium salt.
Metathesis of the resulting complex to form a tetraalkyl ammonium, tetraphenyl phosphonium or bis(triphenylphosphoranylidene) ammonium (PPN/salt tends to yield metal chelate complexes that are easier to purify as compared to the lithium
0 ion containing complexes. The purified metal chelate complex, can then be used to catalyze oxidation reactions.
If the complex is then combined with a strong O-atom transfer oxidant,
AP Ο 0 0 9 1 9
- 36 preferably a peroxide, such as hydrogen peroxide, t-butyl hydroperoxide, cumyl hydroperoxide or a peracid. a ligand metal IV. V or VI oxo intermediate is produced. When oxidatively robust substituents have been employed to generate the ligand framework, the robust, high oxidation state oxo containing species apparently form as reactive intermediates. It is believed that these high valent oxo containing species are the active transfer agents in catalyzing a number of oxidation reactions.
When a low valent metal species is exposed to a peroxide or other [0] containing oxidant the metal attracts and binds the oxygen from the oxidant.
o Depending on the metal, the bond between the metal and the oxygen will be very strong or may be only strong enough to remove the oxygen from the oxidant for subsequent transfer to another constituent.
If the metal is a metal III ion, the resulting oxo species will in general be a metal V ion. If the metal is a metal IV ion, the resulting oxo species will in general contain a metal VI ion or a metal V complex with a second oxidation site on the ligand, i.e., a ligand cation-radical. The combined stabilizing effect of the macrocyclic ligand and the participation of the d electron count at the metal center in controlling the degree of bonding to an oxo ligand tends to favor early transition metal complexes forming very strong oxygen-metal bonds to yield stable oxides.
The middle and later transition metals tend to remove the oxygen from the oxidant and bind the oxo ligand to form a reactive intermediate. In the metal ligand system produced by the new synthetic method, the middle and later transition metals rend to promote the transfer of oxygen.
In addition to its stabilizing effect, the ligand also exerts influence on the
5 metal properties. By controlling the metal, the electron density of the macrocycle, the charge on the complex, and the bond strength/bond order to the coordinated f
oxo ligand, the metal ligand complex can be fine tuned to achieve a complete range of oxygen transfer abilities, from stable oxides to high valent oxidation catalysts.
In the preferred embodiment, the axial ligand, L„ is labile because it
0 occupies its position relative to the metal until the chelate system is^introduced into a solution containing an oxidant. The labile ligand will dissociate ahd will be replaced by the oxidant, most generally an O-atom transfer agent, but also any general oxidant that can serve to activate the metal ion to perform catalysis. Preferred labile ligands include, but are not limited to, the Cl ’ anion, halide ions in general, CN H2O, OH', ROH,NH3, or any amine, carboxylatc, phenol or phenoxide, pyridine, ether, sulfoxide, ketone, or carbonate. The oxidation site in
AP/P/ 9 9/01455
ΑΡ ο ο Ο 9 1 9
- 37 by the choice of axial ligands as well as by the ring substituents.
Macrocycles with spiro-cyclohexyl substituents have been prepared and found to render the macrocycle very hydrophobic and, remarkably, soluble in pentane and other light saturated aliphatic solvents. Long chain substituents, such as a dodecyl chain, or phospholipid chain will render the macrocycle soluble in membranes.
The spiro-cyclohexyl derivative is sterically hindered and has slower reaction rates thanlhe other preferred substituents, so the normal synthesis of the amide intermediate of the first step of the method of the invention is altered.
Synthesis of the bis spiro-cyclohexyl macro linker intermediate was accomplished by adding acylating agent dropwise in multiple aliquots, preferably three, separated in time. Twelve hour intervals preferably followed by extended reaction periods produced the best results. Without the extended reaction periods, the yield was lower. The reaction sequence is shown in the sequences below. Cyclohexane can be used to separate the oxazalone form of the macro linker away from the other reaction products, or water can be added to hydrolyze the oxazalone in situ. Hydrolysis of the intermediate oxazalones provides an increased yield of the desired bis cyclohexyl macro linker product.
1.35
0.
60% yield of these two products
ΌΗ
O' OH v + mono-oxazalone
S 5 I 9 / 6 6 /d/dV
O'
HO' bis-cyclohexyl
MACROLINKER
Synthesis of a bis spiro-cyclohexyl macro linker.
SUBSTITUTE SHEET (RULE 26)
APO 00 9 1 9
oxazalone
°C , 1 day .,- -bis-cyclohexyl Macro Linker
Hydrolysis of a hydrophobic oxazalone
The cyclohexyl-containing macro linker is then ready for ring closure in the same manner as other intermediates of the invention. However, due to the enhanced stability of the spiro-cyclohexyl containing macrocyclic intermediates, separation of the macrocycle from reaction by-products differs from other preferred ring closing constituents. Typically, the crude macrocyclic product is extracted into an organic solvent, such as CH2C12. The CH2C12 solution is washed with acids and bases to remove the impurities and side products that contain acidic and basic functionalities and to hydrolyze any oxazalone containing intermediates. The cyclohexyl tetraamido macrocycle is not well purified by the usual acid/base washes yielding instead an approximately 1:1 mixture of the bis cyclohexy!
0 oxazalone and bis-cyclohexyl tetraamido macrocycle. Pentane extraction of the mixture yields a clean separation. The macrocycle is insoluble and isolated as a powder, while the pentane soluble fraction can be evaporated to yield large crystals of the bis cyclohexyl oxazalone. '
It has been observed that addition of an excess of the substituted malonyl
5 dichloride improves the yield of macro linker with an optimum ratio of about 2 moles of amino acid to 1.35 to 1.5 moles of the substituted malonyl dichloride.
The product mixture includes the macro linker and a mono-oxazalone form of the macro linker which can be readily hydrolyzed to yield additional product. The yield of the method is improved significantly if water is excluded from the reaction
0 solution during ring closure reactions.
Pyridine diamines can also be utilized. The prior art azide synthetic route, which includes a reduction step that also reduces the pyridine ring, does not yield a macrocyclic compound having a pyridine bridge. Amino pendant variations would in ir>
O c£ <
&ί ϋ ί 0 9 1 9
- 39 10 also be tedious to synthesize by the prior art synthesis methods. The amino pendant variations are of considerable interest because they permit the macrocyclic compound or metallocomplex to be tethered to a support, such as a polymer or sand, or to other molecules or substrates having functional groups which wili covalently bond with the amine. Groups which covalently bond with amines are well known in the art and include in complexed form, for example, alkyl amines, amides, sulphoriamides, imines, and other hidden or protected/activated forms, see Table 1.
The synthesis of the aryl amino pendant macrocycle proceeds generally as ' in Sequences 4 and 5. .-.- -15
Seq.(4)'
Synthesis of 1,2-Diamino-4-Acetamidobenzene (dihydrobromide)
The sequence includes the strategic and selective introduction of a protected amino group (an acetamide) onto the aryl diamine group (Bridge). The protected form of the bridge, an acetamido diamine is then suitable for ring closure via the standard diamine + intermediate linker synthetic routes described herein.
An extended ring closure time is required to achieve macrocyclizati.on and is attributed to unfavorable hydrogen bond formation between the attached oxazalone and the acetamido group, which would be expected to slow7 down the desired macrocyclization reaction.
Once the protected amino pendant macrocycle has been synthesized as in sequence 5, it can be metallated with cobalt. Removal of the acetyl protecting group then yields a macrocyclic cobalt complex that is ready to be attached to a support. Best results to date have been obtained by reacylating the pendant amino group with acryloyl chloride to yield an amide linked vinyl pendant macrocycle.
AP/P/ 9 9/01455
AF Ο 3 Ο 9 1 9
Synthesis of an amino pendant macrocyclic cobalt complex
This may then be copolymerized with a twenty fold excess of various acryloyl monomers to yield an acrylic polymer that contains a macrocyclic cobalt complex as a sidechain approximately every 20 residues, shown schematically in Fig· 5.
By anchoring the macrocyclic metal complex to a polymer or some other support, the metal may be reclaimed and recycled according to the system shown schematically in Fig. 4. Environmentally toxic metals, for example CrVI can be replaced by more environmentally benign oxidation reagents, such as<oIV or Co111!? species, where L1 refers to a ligand centered oxidation.
Referring to Fig. 4, following the desired oxidation process, the anchored oxidant can be recycled via collection and reoxidation with a primary oxidant, such as hypochlorite, bromine or by electrolysis. Use of anchored macrocyclic metal species is expected to provide a viable method to significantly reduce the levels of
AP/P/ 9 9 / 0 1 45 5
SUBSTITUTE SHEET (RULE 26)
AP 0 0 0 9 1 9
- 41 discharge of toxic spent metallic species into the environment. The polymer bound oxidant system of Fig. 4 serves as an example of a recyclable Green oxidation reagent.
EXPERIMENTAL SECTION Syntheses of Oxidatively Robust Tetraamido Ligands.
Materials. All solvents and reagents were reagent grade (Aldrich, Aldrich SureSeal, Fisher) and were used as received. Microanalyses were performed by Midwest Microlabs, Indianapolis, Indiana.
Electrochemical Measurements. Cyclic voltammetry was performed under N2 in a three compartment cell using a glassy carbon disk working·electrode (A‘~ 0.0078 cm2 or 0.071 cm2), a Pt wire counter electrode, and a sodium chloride saturated calomel electrode (SSCE) as reference. CH2C12 (Aldrich Sureseal) or CH3CN (dried over CaH2) were employed as solvents with a supporting electrolyte of [Bu4N][C1OJ (0.1 M, Fluka, vacuum dried 24 h °C) or [Bu4N][PF6] (0.1 M, Fluka puriss). A Princeton Applied Research Model 273 Potentiostat/Galvanostat controlled with a Compudyne 486DX computer was used and current/voltage curves were recorded on a Graphtec Model WX1200 X-Y recorder, or using a Princeton Applied Research Model 173/179 potentiostat/digital coulometer equipped with positive feedback IR compensation, a Model 175 universal programmer, and a Houston Instruments Model 2000 X-Y recorder. For some experiments, ferrocene (Fc) was added as an internal potential standard at the conclusion. Formal potentials were calculated as the average of anodic and cathodic peak potentials and are reported vs NHE. Peak-to-peak separation of the FcTFc couple was similar to that of the iron compound couples in all cases. Plots of peak current vs. the square root of scan speed over the range 20-500 mV s'1 were found to be linear for all couples.
Mass Spectrometry. Electrospray ionization mass spectra were acquired on a Finnigan-MAT SSQ700 (San Jose, CA) mass spectrometer fitted with an Analytica of Branford electrospray interface. Electrospray voltages of 2400-3400 V were utilized. Samples were dissolved in either acetonitrile or dichioromethane at /
concentrations of approximately 10 pmol/μΐ and were introduced into the ESI interface prior to data acquisition by direct infusion at a flow rate of 1 μΐ/min. Positive ion electron impact ionization (70 ev) MS experiments were performed on a Finnigan-MAT 4615 quadrupole mass spectrometer in conjunction with an INCOS data system. The ion source temperature was 150°C and the manifold
AP/P/ 9 9/01455
AP Ο 0 0 9 1 9
- 42 chamber temperature was 100°C. Sample introduction was by means of a gas chromatograph or a direct insertion probe. Positive ion fast atom bombardment mass spectra were acquired on a Finnigan-MAT 212 magnetic sector instrument in combination with an INCOS data system. The accelerating voltage was 3 kV and the ion source temperature was approximately 70°C. An Ion Tech saddle-field fast atom gun was employed with xenon at 8 keV. Thioglycerol was utilized as the FAB matrix.JPositive ion electron impact ionization (70 eV) MS/MS experiments were performed on a Finnigan-MAT TSQ/700 tandem quadrupole mass spectrometer. Sample introduction was by means of a direct insertion jprobe. The o ion source was maintained at 150°C and the manifold chamber was held at 70°C.
Collision-induced dissociation (CID) was achieved by introducing argon into the center rf-only collision octapole until the pressure in the manifold reached 0.9-2.5 x 10'6 Torr. The nominal ion kinetic energy for CID product ions was < 35 eV (laboratory reference). High resolution data were obtained on a JEOL JMS AX15 505H double focusing mass spectrometer in the EB configuration using a resolution of 7500. Sample introduction was by means of a gas chromatograph or direct insertion probe. During mass spectral acquisition, perfluorokerosene was introduced into the ion source by means of a heated inlet. Exact mass assignments were obtained by computer-assisted interpolation from the masses of
0 perfluorokerosene. GC/MS conditions: column, 20 m x 0.25 mm DB-1701 (J &
W Scientific); carrier gas, helium with a linear velocity of 40 cm/sec; injector, 125°C; column temperature, 35 °C for 3 min, followed by an increase at 10°C/min to 100°C; injection, split mode, appx. 50:1 ratio.
Spectroscopic Methods. 300 MHz Ή NMR spectra and 75 MHz 13C NMR spectra
5 were obtained on an IBM AF300 instrument using an Oxford Superconducting magnet system, data acquisition was controlled by Bruker software. Infrared spectra were obtained on a Mattson Galaxy Series 5000 FTIR spectrometer controlled by a Macintosh II computer. UV/vis spectra were obtained on a Hewlett Packard 8452A spectrophotometer driven by a Zenith Z-425/SX computer.
0 Conventional X-Band EPR spectra were recorded on a Bruker ER300 spectrometer equipped with an Oxford ESR-900 helium flow cryostat. Mossbauer spectra were obtained on constant acceleration instruments and isomeric shifts are reported relative to an iron metal standard at 298 K. In order to avoid orientation of polycrystalline samples by the applied magnetic field, the samples were suspended
5 in frozen nujol.
AP/P/ 9 9/01455
APO00»19
- 43 Syntheses of Diamines not Readily Available Commercially
Example 1
A. b2-Diamino-4.5-Diroethoxy Benzene from
1,2-Dimethoxy Benzene (veratrole) ,2-Dinitro-4,5-Dimethoxy Benzene: Veratrole was doubly nitrated according to the procedure of Drake et al, in Synthetic Antimalarials. Some Derivatives of 8Aminoquinoline, J. Amer. Chem. Soc., 1536, Vol. 68 (1946). Nitric acid (68.3 g, cone.) was added'(dropwise, 1 h) to a well stirred solution of veratrole (48.3 g, 350 mmol, d = 1.084) in glacial acetic acid (1450 mL) initially cooled to 15°C. The mixture needs to be held below 40°C but above 10°C by cooling and proper regulation of the rate of addition of the acid. Considerable fnononitroveratrole separated out. Stirring was continued and additional nitric acid (212.7 mL, fuming) was added (dropwise, 1 h) while the temperature of the solution was held below 30°C. As the second nitration proceeded the mono nitro veratrole dissolved and when all the acid had been added, the solution was clear. The nitration mixture was allowed to stand for two hours and was then poured into ca. 1.5 L of ice/cold water. The precipitated dinitro compound was filtered, washed copiously with water until free from acid (pH > 5), and recrystallized directly from a minimum of hot EtOH (600 mL). The yield of l,2-Dimethoxy-4,5-dinitrobenzene was 69.0 g (87%). Characterization: m.p. 129.5-130.5 °C. Ή NMR (CDC13) δ [ppm]: 7.35 (s, 2H, ArH), 4.02 (s, 6H, OCH3). IR nujol vfcm'1]: 3124 (s, w, Aryl CH), 3073 (s, w, Aryl CH), 1592 (s, str, Aryl ring stretch), 1535 & 1518 (s, str, ArNO2).
Anal. Calcd. For CgHgN2O6: C, 42.11; H, 3.53; N, 12.28. Found: C, 42.12; H,
3.54; N 12.33.
1,2-Diamino-4.5-Dimethoxy Benzene: l,2-Dimethoxy-4,5-dinitrobenzene (10 g, ί
43.8 mmol) was reduced to l,2-Dimethoxy-4,5-diamino benzene in acidic MeOH (175 mL + 2 eq. of mineral acid, (i.e., 10 mL of cone. HBr)) by catalytic
0 hydrogenation using 10% Pd/C catalyst (24-36 h, 20-22 psi of H2 was consumed from the reservoir). If more than 2 eq. of HBr are added initially the Pd/C catalyst is found to be strongly inhibited. After hydrogenation was complete an additional 4-5 eq. of cone, mineral acid was added to protect the material from aerial oxidation and the mixture rotary evaporated to yield a red/purple oil. The crude
5 material was purified by adding a small volume of Abs. EtOH, then pouring the slurry into a 600 mL volume of ice cold Et2O, with storage in the freezer overnight.
ΑΡ/Γ/ 9 9/01455
AP000919
- 44 The red-purple product was collected by filtration, air dried briefly then stored in a dessicator to complete the drying process. Prolonged exposure of the diamine salt to air/water causes a green color to develop which appears indicative of irreversible oxidation. Hydrogenation yield was ~90%. Characterization of the red-purple 1,25 Dimethoxy-4,5-Diaminobenzene (dihydrobromide salt hydrate). Ή NMR (d5 pyridine) δ [ppm]: 10.35 (s, br, 7.5 H, H2O/py.HBr/R-NH2 rapidly exchanging), 7.35 (s, 2 H^ArH)/3.60 (s, 6 H, ArOCH3). IR (nujol/NaCl) v [cm·']; 3085 (br,
OH), 2557 (s, str, ArNH/), 1623 (s, w, asymmetric NH/ bend/Ary I ring stretch), 1539,1519 (s, m. symmetric NH/ bend). (Anal. Calcd. for C8H12N2O2) (HBr)2 (H2O)0.66: C, 28.09; H, 4.52; N, 8.19. Found: C, 27.82; H, 4.18; N, 8.37.
Independent confirmation of hydration was obtained from IR and NMR spectroscopy.
Preparation of the anhydrous sulfate salt of l,2-Diamino-4,5-Dimethoxy Benzene has been reported by Nakamura, M. et. al. in Fluorimetric Determination of Aromatic Aldehydes with 4,5-Dimethoxy-l ,2-Diaminobenzene Anal. Chim. Acta. (1982), 134, p.39-45 as follows: l,2-Diamino-4,5-Dimethoxybenzene (2 g) was dissolved in EtOH (20 mL) and mixed with H2SO4 (cone., ca. 2 mL). The product was recrystallized from EtOH to almost colorless needles (yield ca. 2 g). Anal. Calcd for CgHI4O6N2S: C, 36.1; H, 5.3; N, 10.5. Found: C, 35.85; H, 5.6;
N, 10.4.
Β. 1,2-Diamino-4-acetamidobenzene from l,4-diamino-2-nitrobenzene (2-Nitro-l,4-phenvlenediamine)
1 -Amino-2-nitro-4-acetamidobenzene: l,4-diamino-2-nitrobenzene(2-nitro-l,4phenylenediamine) was selectively acetylated according to the method of McFarlane et. al, J. Chem. Soc. Perkin Trans., 691 (1988) incorporated herein by reference. The amine meta to .the nitro group is readily acetylated using acetic anhydride in acetone (the amine ortho to the nitro group is strongly deactivated),
0 The yield of 1 - Amino-2-nitro-4-acetamidobenzene (2-nitro-4-acetamido aniline) was > 90%. Characterization; Ή NMR (CD3OD) δ [ppm]: 8.3 (m, 1 H, ArH), 7.5 (Μ, 1 H, ArH), 6.9 (Μ, 1 H, ArH), 2.1 (s, 3 H, acetyl CH3) in good agreement with McFarlane. IR (nujol/NaCl) ν [cm·']: 3470 (s, str, HO Ac), 3340-3150 (m, m/str, acetamide ArNH + ArNH2), 1661 (s, str, acetamide CO), 1643 (s, str, FI bonded
5 acetamide CO), 1592 (s, m/w, aryl stretch), 1547 (s, str, ArNO2) & 1512 (s, m
ArNO2). Anal. (Dried at 80 °C) Calcd for CgH,N3O3: C, 49.23; 1-1, 4.65; N, 21.53. Found: C, 49.36; H, 4.55; N, 21.31.
AP/P/ 9 9 / v 1 4 5 5
APO 0 0 9 1 9
- 45 - , l,2-Diamino-4-acetamidobenzene: l-Amino-2-nitro-4-acetamidobenzenewas reduced to l,2-Diamino-4-acetamidobenzene in acetic acid (HOAc)/MeOH using catalytic hydrogenation over a 10% Pd/C catalyst. The material was isolated as the dihydrochloride salt. Yield >90%. Characterization: 'H NMR (CD3OD) δ [ppm]: 6.94 (m, 1 H, ArH), 6.68 (m, 1 H, ArH), 6.62 (m, 1 H, ArH), 2.1 (s, 3 H, acetyl CH3). IR (nujol/NaCl) v [cm'1]: 3348 (s, str, acetamide ArNH), 3226-3100 (nr, m, ArNH2), 25S8 (s, br, str, ArNH/)> 1649 (s, str, acetamide CO), 1623 (s, str, H bonded acetamide CO). Anal. (Dried at 80 °C) Calcd for C8H13N3OC12.
(HCl/H2O)01: C, 39.45; H, 5.50; N, 17.25; Cl, 30.57. Found: C, 39.39; H, 5.53;
N, 17.32; Cl, 30.37. Presence of solvate HCI/H,0 was confirmed by IR, and is consistent with the constant boiling 36.5-38% HCI used to generate the hydrochloride salt.
C. 2.4-Diamino-2,4-Dimethyl Pentone from 2,4-dimethylpentanone
2.4- Dibromo-2,4-dimethylpentanone: To 2,4-dimethylpentanone (85 mL, 68.5 g,
O. 60 mol) in CC14 or 1,2 Dichloroethane (1 L) was added N-bromo-succinimide (NBS, 240 g, 1.35 mol, 2.26 equiv). The mixture was heated under reflux, and benzoyl peroxide (ca 20 mg) was added to the refluxing mixture. While the solution was heated under reflux (24 h), a pale orange solid (succinimide) floated to the surface of the halogenated solvent, while unreacted NBS remained at the bottom. Benzoyl peroxide was repeatedly added to the refluxing mixture (ca 20 mg; 12-24 hr intervals) until no NBS was visible, usually the reaction was complete after 24 hours. When the reaction was complete, the solids were collected by filtration and discarded, the halogenated solvent/Br2 was removed from the mother liquor under reduced pressure, leaving a pale yello\y oil. To remove residual halogenated solvent, 95% EtOH (100 mL) was added, solvents were again removed under reduced pressure, and a yellow slightly impure oil
0 resulted (159.99 g, 0.59 mol, 98%). Ή NMR (CDC13): 2.1 (s). IR (neat/NaCl) v [cm'1]: 3375 (s, w, impurity OH), 3014, 2978, 2933 (s, str, CH), 2858 (s, w, CH), 1701 (s, str, ketone CO).
2.4- Diazido-2.4-dimethylpentanone: A solution of 2,4-Dibromo-2,43 5 dimethylpentanone prepared as above or purchased from Lancaster Synthesis (89.8 g, 0.33 mol) in EtOH (1.2 L, 95%) was added to a solution ofNaN3 (Caution!, 47.2
AP/P/ 99/01455
AP000919
- 46 g, 0.726 mol, 2.2 equiv) in water (0.6 L). The solution was heated under reflux (16 h) to give a pale orange solution. The EtOH was removed under reduced pressure until the solution became cloudy. The cloudy aqueous solution was extracted, still warm, with pentane (500 mL) three times, and the combined extracts were dried over Na2SO4 and concentrated to 300 mL under reduced pressure. Glacial acetic acid (100 mL) was then added, and the remaining pentane was removed under reduced pressure. This workup was required to remove any excess NaN3 since the product is exposed to Pd/C in the next step, and care should be taken to avoid the formation of heavy metal azides (due to the risk of explosion). The solvent was removed from a small sample under reduced pressure to give a neat oil (< 20 mg) for spectroscopic characterization: Ή NMR (CDC13): 1.54 (s). IR (neat) v [cm'']: 2115 (RN3), 1720 (ketone CO). It should be noted, for safety, that the organic azides produced in this and related azide based syntheses are never isolated in concentrated forms or as solids in quantities greater than 20 mg.
2,4-Diamino-2.4-dimethylpentan-3-one: Glacial acetic acid (50 mL) was added to the HOAc solution of the dialkyl azide formed in the previous step, and this solution was added to 10% Pd/C (2.7 g). The mixture was hydrogenated at 50 psi (1 week) in a Parr hydrogenator. Because the reaction evolves one N2 molecule for every H2 molecule absorbed, the bomb was evacuated and repressurized 10 times with H2 to 50 psi. (H2 from the high pressure reservoir is not efficiently consumed.) The charcoal was removed by filtration, and HOAc was removed under reduced pressure. After HBr was added (48%, 76 mL), the mixture was dissolved in EtOH. The volatiles were removed under reduced pressure to yield a
5 tan solid, which was washed with a mixture (200 mL) of THF (50%), EtOH (45%), and cone. HBr (5%) or with a mixture of THF (95%) and cone. HBr (5%). The resulting white powdery product was the dihydrobromide salt of 2,4-Diamino-2,4dimethylpentan-3-one (56.2 g, 48% from 2,4-Dibromo-2,4-dimethylpentanone), Additional product may be collected from washings that have been pooled from several different preparations. The product must be stored as the diltydrobromide or dihydrochloride salt to protect the amines from oxidative degradation. Characterization: 'H NMR (CDCl3/DMSO-d6) of 2,4-diamino-2,4-dimethylpentan-3-one . 2 HBr: 8.62 (6FI, s, br, NH3), 1.77 (12 1-1, s, Me). IR (free base, nujol mull) v [cm'1]: 3460-3160 (RNH2), 1690 (ketone CO). Anal. (Dried at 80
5 °C) Calcd for C7H16N2O . (HBr)/. C, 27.47; H, 5.93; N, 9,15; Br, 52.22. Found:
C, 27.43; FI, 5.91; N, 9.11; Br, 52.46.
AP/P/ 9 9/01455
AP O Ο Ο 9 1 9
- 47 Syntheses of Macrocyclic Tetraamido-N Donors Ligands
Example 2
Macro Linker Intermediate (A-L-A) synthesis, from a-methyl alanine and dimethyl malonvl dichloride (a Tetramethvl Dimethyl substituted intermediate).
Hexamethvl (HM) Intermediate
Place a two-neck flask (1 L) fitted with a pressure equalizing addition’funnel (250 mL) and a septum under N2. Add α-amino isobutyric acid (i.e. ct-methyl alanine) (20.62 g, 0.2 mol) and dry pyridine (250 mL, dryed over 4 A mol sieves) to the flask and heat 55-65°C with stirring, then add dimethyl malonyl dichloride (17.8 mL, 0.135 mol) dissolved in dry pyridine (100 mL, dryed over 4.A mol sieves) to the addition funnel. Add the contents of the addition funnel (dropwise, 1 h) to the reaction and the allow the acylation to proceed (60-70°C, 30-36 h) under N, or with a drying tube fitted. Once the acylation is complete, quench the reaction by adding H2O (30 mL) and stirring (60-70°C, 24 hrs). Reduce the solvent volume on the rotary evaporator to give an oil, then add HCI (cone., ca. 25 mL) to a final pH of 2-3. Set the hot solution in the refrigerator (4°C , 15 h), and the collect the resulting product by frit filtration, and wash thoroughly with acetonitrile (2 x 100 mL). The air-dried white product, (16.5 -19.8 g, 45-60%. yield) should be stored in a dessicator. This product is usually pure enough for ring closure reactions, but recrystallization may occasionally be required. Characterization: Ή NMR (d5 pyridine, δ [ppm]); 9/2-9.8 br s, 2 H (carboxylic OH), 8.23 s, 2 H (amide), 1.87 s 12 H (CH3), 1.74 s 6 H (CH3). IR (nujol/NaCl) v [cm'1]: 3317.0 (amide NH); 1717.9 (carboxylic CO); 1625.7 (amide CO). Anal, (dried at 100 °C) Calcd. for
C|3H22N2O6; 0 51.63, H 7.34, N 9.27. Found; C 51.64, H 7.35, N 9.33.
Example 3 ;
Large Scale, Macro Linker Intermediate (A-L-A) synthesis, from a-methyl alanine and diethyl malonyl dichloride (a TMDE substituted intermediate),
0 If a large scale synthesis is desired, a two-neck flask (2 L, RB + Claisen) should be fitted with a pressure equalizing addition funnel (250 mL) and septa, and placed under N,. Add α-aminoisobutyric acid (i.e. α-methyl alanine) (90.3 g, 0.9 mol) (or any a- or β-amino described herein), cannulate anhydrous pyridine (1.4 L, sure seal) into the flask and heat the reaction mix to 45-55°C and stir. Cannulate
Pyridine (100 mL, sure seal) and then dimethyl malonyl dichloride (104.4 mL, 0.61 mol) into the addition funnel. Add the contents of the addition funnel (dropwise.
S S H 0 / 61 /d/dV ~ A,..;
AP000918
- 48 3-4 h) to the reaction, remove the addition funnel, and allow the acylation to proceed (55-65°C, 120-130 h) under N,. Once the acylation is complete, quench the reaction by adding H2O (100 mL) and stirring (60-70°C, 24-36 hrs). Reduce the solvent volume on the rotary evaporator to give an oil, then add HCI (cone., ca.
110 mL) to a final pH of 2-3. Set the hot solution in the refrigerator (4°C, 15 h), and collect the resulting product by frit filtration, and wash thoroughly with acetonitrile (700 mL·, 150 mL) by stirring in an erlenmeyer flask. Crush the airdried white product (87.9 g, 60% yield), in a mortar and pestle and store in a dessicator. The large scale reaction amide intermediate product is more likely to need recrystallization before use in ring closure reactions. - ' ' '
Example 4
Recrystalization of HM Intermediate
Crude intermediate from Example 2 or 3 (50.4 g, 0.153 mol) in H2O (slightly less than 500 mL, deionized) is dissolved by adding Na2CO3 (16.2 g, 0.153 mol) in three aliquots slowly and carefully to avoid excessive frothing. Stir good and heat mildly. Bring the solution to a boil, filter and acidify with I-ICl (cone., 30 mL, 0.36 mol). Allow the solution to cool (overnight, 4°C) and filter the precipitate off and wash with acetonitrile (250 mL). The air dryed product (38.8-45.4 g, recryst. yield
0 77-90%) should be stored in a dessicator.
Macrocyclization Reactions
Several synthetic routes for the preparation of macrocyclic tetraamido ligands have been developed. The organic azide based route is described in Uffelman, E.S., Ph.D. Thesis, California Institute of Technology (1992) and
Kostka, K.L., Ph.D. Thesis Carnegie Mellon University (1993). Examples of several synthetic routes for the preparation of macrocyclic tetraamido ligands using a new synthetic method follow.
Phosphorus Trichloride Coupling
Phosphorus trichloride coupling of the amide intermediate reaction product to aromatic 1,2-diamines yields macrocyclic tetraamides safely, cheaply and in high yield. Two distinct variations of the PC13 coupling method are useful, the differences relate to the order of addition and choice of reagents utilized. These methods are applicable to the preparation of a wide variety of different macrocycles with different electronic substituents present on the bridge diamine, or steric substituents present on the amide intermediate, primarily because of the parallel incorporation of the macro linker type of amide intermediates into ail of
AP/P/ 99/01455
APO 0 0 9 1 9
- 49 the syntheses.
Example 5
A. Macrocycle Synthesis via PCI, Coupling
A long neck flask (250 mL) is charged with the amide intermediate of Examples 24, (10 mmol) and a stir bar and then baked in the oven (80-100°C, 30-45 mins).
The hot flask is placed under N2, aryl diamine (10 mmol) is added and anhydrous pyridine (50 mL, sure seal) cannulated in. The flask is heated (50-60°C) and PC13 (d = 1.574 g/mL, 1.72 mL, 20 mmol) syringed in as quickly as possible without excessive refluxing. This is an exothermic reaction, so caution should be used.
The temperature is then increased to reflux or just below reflux (100-115°C) and the reaction allowed to proceed under N2 (48 h). After the acylation is complete, the contents of the flask are acidified with HCI (1 eq., ca. 60 mL) to a final pH ~2. The mixture is transferred to an erlenmeyer (water is used to rinse the flask) and stirred with CH2C12 (300 mL, 2-3 h), then extracted with additional CH2C12 (2 x 150 mL). The combined organic layers are washed with dilute HCI (0.1 M, 2 x 100 mL) followed by dilute aqueous Na2CO3 (2 x 5g/l 00 mL). The organic solvents are removed on the rotary evaporator to yield crude product (30%). The weight of crude product is usually equivalent to the initial weight of diamine.
B. Macrocycle Synthesis via PCI, Coupling
A long neck flask (250 mL) is charged with MgSO4 (5 g), a stir bar, aryl diamine (10 mmol) and pyridine (50 mL, dryed over 4 A mol sieves) then placed under N2. PC13 (d = 1.754 g/mL, 1.72 mL, 20 mmol) is added via syringe and the mixture brought to reflux for 30 mins, an orange/yellow precipitate forms. The mixture is cooled somewhat, an amide intermediate (10 mmol) is added, then the mixture is refluxed under N2 (115°C, 48 h). After the acylation is complete, the contents of the flask are acidified with HCI (1 eq., ca. 60 mL) to a final pH «2, The mixture is transferred to an erlenmeyer and stirred with CH2C12 (300 mL, 2-3 h), then
0 extracted with additional CH2C12 (2 x 150 mL). The combined organic layers are washed with dilute HCI (0.1 M, 2 x 100 mL) followed by dilute Na2CO3 (2 x 5g/l 00 mL). The organic solvents are removed on the rotary evaporator to yield crude product (30%). The weight of crude product is usually equivalent to the initial weight of diamine.
5 Note: For larger scale macrocyclization reactions, the ring closure times are increased to 4-5 days at reflux, and most of the pyridine present at the end of the
AP/P/ 9 9 / 0 1 4 5 5
AP 0 ϋ ϋ 9 1 9
- 50 reaction is removed via rotary evaporation prior to acidification.
Example 6
HM-DCB from HM Intermediate + DCB Diamine 5 l,2-Diamino-4,5-Dichlorobenzene (1.77 g, 10 mmol) was utilized as the-diamine with Hexa Methyl amide intermediate (3.02 g, lOmmol) in the PC13 method A or B macrocyclization reaction. The crude macrocycle (1.33g, 30%) was recrystallized from a minimum of hot n-propanol by evaporation, 1st crop recrystallization yield was 60%. Characterization: 'H NMR δ [ppm]: 7.69 (s, 2 H, ArH), 7.35 (sv2_H, amide NH), 6.44 (s, 2 H, amide NH), 1.58 (s, 12 H, arm methyls), 1.53 (s, 6 H, malonate methyls), small n-propanol peaks were noted. IR (nujol/NaCl) v [cm’]: 3503 (s, br, m-w, n-propanol OH, 3381 (sh, m, amide NH), 3338 (s, str, amide NH), 1689 (s, str, amide CO), 1643 (s, str, amide CO). Anal. Calcd. for C)9H24N4O4C12 . (C,HgO)0.2: C, 51.70; H, 5.57, N 12.30% Found C, 51.69; H, 5.63;
N, 12.33%.
Oxazalone Coupling Reactions
Oxazalone coupling of the amide intermediate to aromatic diamines also yields macrocyclic tetraamides safely, cheaply and in high yield, but with less sensitivity
0 to additional functional groups. The macrocycles able to be formed via the PCi3 coupling route can also be manufactured via the oxazalone coupling route. In addition, the lesser sensitivity to additional functional groups has opened up the preparation of macrocyclic ligands with additional functional groups designed to confer new properties on the resulting metal complexes. Specific examples include
5 the incorporation of reactive groups (such as amine or vinyl groups) attached in a pendant fashion to the aryl ring of the macrocycle allowing for covalent attachment of the preformed macrocycles to some (polymeric) substrate.
Example 7
0 Macrocycle Synthesis via Oxazalone Method
A long neck flask (250 mL) is charged with amide intermediate (3.3 g, 10 mmol), a stir bar and then baked in the oven (80 - 100°C, 30-45 mins). The hot flask is fitted with a septum and placed under N2. Anhydrous pyridine (50 mL, sure seal) is cannulated in and heating commenced while trimethyl acetyl chloride (i.e. pivaloyl
5 chloride) (22 - 24 mmol) is added via syringe. The temperature is increased to reflux or just below reflux (100-115°C) and the reaction allowed to proceed under
AP/F/ 8 9/01455
APO00919
- 51 N2 (22-26 h) being careful to avoid cross contamination from other reactions on the N2 line. The reaction goes from a clear pale yellow to a yellow-brown color. After oxazalone formation is complete5, the aryl diamine (8-10 mmol) is added either as a neat solid or via large bore cannula as a slurry in anhydrous pyridine, or dissolved and degassed under N2 in anhydrous (sure seal) pyridine, if head space and solubility constraints can be satisfied. The ring closure reaction is refluxed for a further 48-72 hours (longer times for larger scales) under N, without- cross contamination from other reactions. The mixture will usually turn brownish black. Once the acylation is complete, the reaction is quenched by adding H2O (30 mL) and stirring at reflux (100°C, 22-26 hrs). The mixture is cooled and transferred to an RB flask (500 mL) using a minimum of H,0 to rinse the long neck flask. The solvent is removed via rotary evaporation to yield the crude product mixture as an oily tan to brownish black solid. It should be noted that, functional groups permitting, the crude product mixture can be taken up in CH,C12 and washed with dilute aqueous HCI and dilute aqueous Na,CO3. Removal of the organic solvent at reduced pressure then yields the normal macrocyclic product familiar from the PC13 coupling reactions and suitable for direct recrystaliization as detailed previously to yield pure macrocyclic product.
5Pumping an aliquot down and redissolving in dry d5 pyridine yielded a dominant species (>80% bis oxazalone after 24 h at reflux) with 'H NMR d [ppm]: 2.10 (q. 4 H, methylene CH2's), 1.38 (s, 12 H, RCH3), 0.85 (t, 6 H, ethyl CH3’s). Addition of water to the NMR sample regenerated the normal amide intermediate spectrum
5 after about 20 h at RT.
Example 8 (
TMDE-AcB from TMDE Intermediate + AcB Diamine via oxazalones.
This macrocycle is the protected form of an amino pendant macrocycle which can
0 be attached to a range of different supports through amide formation between the substrate and the pendant amino group. Due to what is speculated to be formation of an unfavorable hydrogen bond, the ring closure reaction requires,lengthy reflux times in order to achieve macrocyclization. 1,2-Diamino-4-acetamidobenzene dihydrochloride (9 mmol) was employed as the diamine in an oxazalone ring
5 closure reaction. The macrocyclization time was increased (reflux, 5 days), followed by the normal quenching reaction and acid base workup to yield a
APO009t8
- 52 mixture of a triamido containing macrocyclic imidazole and the desired tetraamido macrocycle. Further purification was by silica gel chromatography (1 x 4-5) using acetonitrile as the eluant. Alternatively, the crude product can be purified by recrystallization from hot ethanol, chloroform or dichloroethane. Yield 15-20% from diamine. Characterization: ’H NMR (CD3CN) δ [ppm]: 8.31 (s, 1 H, aryl acetamide NH), 752 (m, 1 H, ArH), 7.55 (s, 1 H, aryl amide NH), 7.44 (s, 1 H, aryl amide NH), 7.30 (m, 2 H, ArH), 6.86 (s, 2 H, alkyl amide NH), 2.05 (q, 4 H, ethyl CH/s), 2.01 (s, 3 H, acetyl CH3), 1.49 (d, 12 H, RCH3*s), 0.82 (t, 6 H, ethyl CH/s). IR (nujol/NaCl) v [cm'1]: 3368 (s, m, amide NH), 3319 (s, m, amldeNH),
3291 (sh, m, amide NH), 3268 (s, str, amide NH), 1678 (sh, m, amide CO), 1667 (s, str, amide CO), 1656 (s, str. amide CO), 1639 (sh, m, amide CO), 1608 (s, m, aryl ring/amide). Anal. Calcd for C23H33N5O5. (I-]2O))25: C, 57.31 H, 7.42 N, 14.53 Found: C, 57.02; H, 7.15; N, 14.33. Presence of solvate H2O was confirmed by Ή NMR and IR.
Example 9
Synthesis of a peralkylated macrocycle (MAC*), or TMDM-DMP from the
TMDM intermediate + 2,4-Diamino-2.4-dimethyl-Pentan-3-one (DMP) via the
0 Oxazalone Route.
The PC13 route to H4[MAC*] (TMDM-DMP) fails to produce appreciable amounts of macrocycle due to what is speculated to be unfavorable complex formation between the diamine ketone functionality and the phosphorus reagent. Unlike tire PCl3 route, which is heterogeneous, the oxazalone route to H4[MAC*] is a homogeneous
5 solution method which simplifies the application of diagnostic techniques such as 'H
NMR to diagnose causes of synthetic failure. Reaction of TMDM bis oxazalone with DMP diamine in dry pyridine fails to form any amides (by NMR analysis). Since the oxazalone route is insensitive to ketone functionalities, the failure to form amides was attributed to acid salt formation of the alkyl amine functionality, the alkyl
0 diamine is 3-4 pKa units more basic than pyridine while aryl diamines have pKa's close to that of pyridine. Therefore, a more basic high boiling solvent '’(triethylamine, tripropylamine, diethylaniline) may be used to increase the amount of amide formation. For amine containing solvents, the presence of water and impurity amines is problematic considering the low solubility of the reactants. Addition of a lewis
5 acid drying agent was found to be beneficial. An appreciable yield of H4[MAC*] can be obtained (2-3% macrocyclization yield, unoptimized) from the reaction (1 step) of
APO 0 0 9 1 9
- 53 TMDM bis oxazalone with DMP alkyl diamine in refluxing tripropylamine + CaO. Isolation of the product should be by fractional recrystallization from toluene in combination with *H NMR analysis.
The highest possible yield of H4[MAC*] from alkyl diamine via the prior art 5 method of Uffelra.an (4 steps from the alkyl diamine) is 8-10%. H4[MAC*] can be obtained in appreciable yield via the oxazalone route.
Synthesis of Chelate Complexes
The compounds labeled 2, 3, 4 and 5 in the following examples are the dimethyl counterparts of those illustrated in Fig. 6.
Example 10 fEt,N]2 and [ΕνΝ13, ithe tetraethylammonium salts of ironflll) chloro TMDMDCB monoanion and ironflll) aquo TMDM-DCB monoanion respectively!.
The parent macrocyclic tetraamide of any of the foregoing examples (525 mg,
1.1 mmol) is dissolved in tetrahydrofuran (40 mL, Aldrich) under N2. Tertbutyllithium under N2 (2.6 mL, 4.4 mmol, 1.7 M in 2,4-dimethylpentane, Aldrich) is added to the solution under N2 at -108°C. Ferrous chloride (anhydrous, 155 mg,
1.2 mmol, Alfa) is added and the solution is warmed to’ room temperature with stirring (16 h), to yield a precipitate, an air sensitive FeL complex. Air is admitted through a drying tube (2 h), and the solid is collected and washed with CH2C12 (2 x 10 mL). The resulting powder is dried under reduced pressure. Yield: 595 mg («93%). Because of variable solvation and limited solubility, the lithium salt should be converted to the tetraethylammonium salt for further use. The lithium salt (595 mg) in CH3OH (50 mL) is loaded on an ion exchange column (Dowex®
50X2-100, 25 g, 2 cm x 12.5 cm) that is presaturated with [Et4N]+ catibns, and the band is eluted with CH3OH (100 mL). The solvent is removed under reduced pressure. The residue is suspended in CH2C12 (20 mL) and the mixture filtered.
The solvent is removed from the mother liquor under reduced pressure giving a hygroscopic glassy residue of [Et4N]2 that may be used without further
0 purification. IR (Nujol/NaCl, cm'1): 1619 (v(CO)amide), 1575 (v(CO)amide),
1534 (v(CO)amide). Careful purification of an iron(III) starting material is more conveniently approached by dealing with the axial aqua monoanionic complex rather than this axial chloro dianionic complex. [Et4N]2 (550 mg, ca. 0.7 mmol) was dissolved in CH3CN (50 mL). Silver tetrafluoroborate (140 mg, 0.7 mmol) is
5 dissolved in CH3CN (2 mL) and added to the solution which is stirred (1 h). The
AP/P/ 9 9 / 0 1 4 5 5
AP O 0 0 9 1 9
- 54 AgCl precipitate is filtered off and the solvent removed under reduced pressure.
The resulting [Et4N]3 is further purified by elution through a silica gel column (8% MeOH in CH2C12). The solvent is removed under reduced pressure and the product is recrystallized from H2O.
Example 11 [Ef N14. [the tetraethylammonium salt of ironflV) chloro TMDM-DCB monoanionl. [Et4N]2 (500 mg, ca. 0.6 mmol) was dissolved in CH2C12 (30 mL). Ammonium cerium(IV) nitrate (10.3 g, 18.3 mmol) is added to the solution and the mixture stirred (2 h). The solid cerium salts are removed by filtration. The product is obtained by removing the solvent under reduced pressure and drying under vacuum.
Example 12
Synthesis of ΓΡ1~ι„Ρ15 [the tetraphenylphosphonium salt of ironflV) cyano TMDMDCB monoanionl from [Et4N]4 [the tetraethylammonium salt of ironflV) chloro
TMDE-DCB monoanion) and NaCN.
[Et4N]4 [the tetraethylammonium salt of iron(IV) chloro TMDM-DCB monoanion] (225 mg, 0.33 mmol) is suspended in H2O (10 mL). Sodium cyanide (140 mg,
0 2.85 mmol) is dissolved in H2O (10 mL) and added to the suspension and the mixture sonicated (Branson 1200, 0.5 h). The mixture is filtered and the blue product is precipitated by adding PPh4Cl [tetraphenylphosphonium chloride] dissolved in water (600 mg, 1.6 mmol, 10 mL, Aldrich). The precipitate is collected and washed with H2O (2x10 mL). The material should be!extracted
5 from the silica gel with CH3CN:CH,C12 (1:1, 60 mL). The solvent is removed under reduced pressure and the residue dissolved in CH2C12 (3 mL) and filtered. Addition of pentane (150 mL) will give a powder (90 mg, 0.10 mmol).
Example 13
0 The Synthesis of[Ph<P]5 [the tetraphenylphosphonium salt of ironflV) cyano
TMDM-DCB monoanion] from Nitrile Cyanide Sources. .
[Ph„P]5 [the tetraphenylphosphonium salt of iron(IV) cyano TMDM-DCB monoanion] can be formed in the presence or absence of base. In the absence of base, the color fades as the solvent is removed in the workup procedures.
5 Therefore, product isolation to obtain the solid is best carried out in the presence of
AP/P/ 99/D1455
AP ΰ ύ ϋ 9 1 9
- 55 >
added base at a pH range of 9-10. The following reaction will yield 5 with each of CH3CN, CD3CN, CH3CH2CN and (CH3)2CHCN as the solvent substrates. Base is not added to the catalytic reactions described.
Example 14
The Synthesis of ΓΡ1ι,,Ρ15 in the Presence of Base, [Et4N]3 (160 mg, 0.23 mmol) is dissolved in the chosen nitrile solvent (6 mL). See Example 13. Tetraethylammonium hydroxide base is added (20 wt %, 0.370 mL, 0.52 mmol, Aldrich), then t-butyl hydroperoxide (90%, 0.605 mL, 5.4 mmol,
Aldrich) is added dropwise with stirring (20 min) resulting in a blue solution. The remaining nitrile is removed under reduced pressure, leaving an oily residue which is dissolved in PI2O (15 mL) and filtered. The material is precipitated from the filtrate by addition of an aqueous solution of PPh4Cl (800 mg, 2.1 mmol, Aldrich, 10 mL). The blue precipitate is collected and washed with H2O (2 x 10 mL).
Yield: 130 mg, 0.15 mmol (65%). Further purification was carried out as described in the [Ph4P]5 section, Example 12.
Example 15 l-i2-f(E)-2-butenyl-2-ethvlamido)-2-methvlpropanamido1-2-F5.52 0 dimethvlhydantoinl-4.5-dichlorobenzene (i.e. a ligand decomposition product).
[Et4N]2 (130 mg, 0.13 mmol) is dissolved in CH3CN (5 mL, Aldrich). A 90% solution of t-butyl hydroperoxide (0.445 mL, 4 mmol, Aldrich) is added slowly (3 min). The reaction mixture is stirred (25 min) and then all liquids removed under reduced pressure. The residue is dissolved in CH2C12 and loaded onto a preparative
5 thin layer chromatography (TLC) plate (Silica gel GF, 1000 mm, 20 cm x 20 cm) and eluted with a 15% CH3CN/ 85% CH2C12 solvent mixture. The product band is detected under UV irradiation at an Rf value of 0.3. The portion of the silica that contains the product is removed from the preparative plate and the product should be extracted with CH2C12:CH3CN (1:1). The solution is filtered and the solvent removed under reduced pressure. A solid is obtained by dissolving the residue in CH2C12 (3 mL) followed by addition of pentane (150 mL). This is collected by filtration and washed with pentane (2x10 mL).
Some examples of specific embodiments of the macrocyclic compounds of the present invention are disclosed in U. S. patent application No. 08/684,670 of
T. Collins et al., entitled Metal Ligand Containing Bleaching Compositions.
Claims (19)
- What we claim is:1. A compound comprising:a macrocyclic tetradentate ligand of the structure selected from the group consisting of substituents which are unreactive, form strong bonds intramoiecularly with said R, and R2 and with the cyclic carbon C,, are sterically hindered and are conformationally hindered such that oxidative degradation of the metal complex of the compound is restricted when the complex is in the presence of an oxidizing medium;Z is an oxidation resistant metal complexing atom;X is an oxidation resistant functionality;R3 is a unit joining the adjacent Z atoms comprised of ' wherein Ri, R7, Rs and R^ pairwise and cumulatively are the same or different and each is selected from the group consisting of alky 1, aryl, halogen, and CF/, and3 0 R4 is a unit joining the adjacent Z atoms comprised ofΑΡΟ00919 wherein Rj0, R,j, Rj2 and R13 pairwise and cumulatively are the same or different and each is selected from the group consisting of alkyl, aryl, halogen and CF3;R5 is a unit joining adjacent Z atoms selected from the group consisting of (i) wherein R14, R15, R16 and R„ are the same or different and each is alkyl, aryl, halogen, or CF3, and (ii) mono-, di-, tri- and tetra-substituted aryl and heteroaryl substituents.
- 2. The compound recited in claim 1 wherein the aryl and heteroaryl substituents compriseAP/P/ » 9 / u 1 4 5 5
- 3 0 wherein each Y is the same or different and comprises halogen, hydrogen, alkyl Ap000919-58-.aryl, amino, substituted amino, nitro, alkoxy, aryloxy and combinations thereof.3. The compound recited in claim 1 wherein each Z is the same or different from one or more other Z’s and each is selected from the group consisting of nitrogen and oxygen.
- 4. The compound recited in claim 1 wherein at least three of the Z atoms are nitrogen.
- 5. The compound recited in claim 1 wherein each X is the same or different from the other X and each is selected from the group.consisting-of oxygen and NRS, wherein Rs is methyl, phenyl, hydroxyl, oxylic, CF3, or CH2CF3.
- 6. The compound recited in claim 1 wherein each of R, and R, are selected from the group consisting of hydrogen, halogen, methyl, CF3 and, if linked, cyclopentyl or cyclohexyl.
- 7. A chelate complex of the formula;ChAP/P/ 99/01455 wherein:M is a transition metal;Z is a donor atom;Ch,, Ch2 and Ch3 are oxidation resistant chelate groups which are the same or different and which form 5- or 6-membered rings with said metal; and, wherein R, and R, are the same or different, linked or unlinked and each i s selected from the group consisting of substituents which are unrcaclive, form strong bondsAU C Ο 9 1 9- 59 intramoiecularly within said R, and R, and with the cyclic carbon C,, are sterically hindered and are conformationally hindered such that oxidative degradation of the complex is inhibited when the complex is in the presence of an oxidizing medium.5
- 8. The complex recited in claim 7 wherein Rj and R2 each is selected from the group consisting of hydrogen, halogen, methyl, CF3 and, if linked, cyclopentyl or cyclohexyl.
- 9. f The. complex recited in claim 7 wherein the metal is selected from the group consisting of Cr, Mo, W, Mn, Tc, Re, Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt,1C Cu, AgandAu.
- 10. The complex recited in claim 7 further comprising at least one ligand bound to M.
- 11. The complex recited in claim 7 wherein Ch, is a constituent selected from the group consisting of C6H2Y2, C6H,Y,,15 R,o R-ioC6Y4, C5H3N, or C4H2N2 RuC-CO-CR,,. wherein Y is halogen, hydrogen, alkyl. CH3, NH2 or CHO. and R,o and R,, are the same or different and each is alkyl, aryl, hydrogen, halogen, or CF,.
- 12. The complex recited in claim 7 wherein the metal is a transition2 0 metal.
- 13. The complex recited in claim 7 wherein the transition metal is one selected from Groups 6, 7, 8, 9, 10 or 11 of the Periodic Table of the Elements.
- 14. The complex recited in claim 7 wherein R, and R2 are linked to form, together with the cyclic carbon to which both are bound, a five-membered25 ring.
- 15. The complex recited in claim 7 wherein R, and R2 are linked to form, together with the cyclic carbon to which both are bound, a six-membered ring.
- 16. The compound recited in claim 7 wherein said at 'east one ligand is3 0 an oxygen containing substituent.
- 17. The compound recited in claim 16 wherein said at least one ligand is selected from the group consisting of peroxide, OH2, 0 and OH. 'S S V I· 0 / 6 6 /d/dVAP Ο 0 0 9 1 9- 60
- 18. An intermediate for the preparation of macrocyclic tetradentate compounds comprising the structure R1 R2 wherein 2 is an oxidation resistant metal complexing atom;R, and R2 are the same or different, linked or unlinked and each is selected from the group consisting of substituents which are unreactive, form strong bonds intramolecularly within R, and R2 and with the cyclic carbon C„ are sterically hindered and conformationally hindered and combinations thereof sufficient for restricting the substituent from oxidative degradation when the intermediate is in the presence of an oxidizing medium;X is a functional group;R3 is a unit joining the adjacent Z atoms comprised ofAP/P/ 99/01455 wherein R(l, R,, Rx and R,, pairwise and cumulatively are the same or different and 2 5 each is selected from the group consisting of alkyl, aryl, hydrogen, halogen, halogenated alkyls, halogenated aryls and CF-,; andAP000919 t » ι» *- 61 R4 is a unit joining the adjacent Z atoms comprised of wherein R10, R,,, R,2 and R13 pairwise and cumulatively are the same or different and each is selected from the group consisting of alkyl, aryl, hydrogen, halogen, halogenated alkyls, halogenated aryls and CF3.
- 19. The intermediate recited in claim 16 wherein each of R, and R2 is selected from the group consisting of hydrogen, halogen, methyl, and CF3, and, when linked, together with the C, carbon to which both are bound, form 3 fivemembered ring or a six-membered ring.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/681,237 US5847120A (en) | 1996-07-22 | 1996-07-22 | Long-lived homogenous oxidation catalysts |
PCT/US1997/012803 WO1998003263A1 (en) | 1996-07-22 | 1997-07-21 | Long-lived homogenous oxidation catalysts |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9901455A0 AP9901455A0 (en) | 1999-03-31 |
AP919A true AP919A (en) | 2000-12-29 |
Family
ID=24734398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1999/001455A AP919A (en) | 1996-07-22 | 1997-07-21 | Metal chelate complexes for foming oxidation catalyst. |
Country Status (21)
Country | Link |
---|---|
US (2) | US5847120A (en) |
EP (1) | EP0914206B1 (en) |
JP (2) | JP2000515152A (en) |
KR (1) | KR100491450B1 (en) |
CN (1) | CN1121906C (en) |
AP (1) | AP919A (en) |
AT (1) | ATE229372T1 (en) |
AU (1) | AU729102B2 (en) |
BR (1) | BR9710513B1 (en) |
CA (1) | CA2261589C (en) |
DE (1) | DE69717819T2 (en) |
DK (1) | DK0914206T3 (en) |
ES (1) | ES2188969T3 (en) |
HK (1) | HK1020176A1 (en) |
IL (1) | IL128150A0 (en) |
NO (1) | NO326043B1 (en) |
NZ (1) | NZ333797A (en) |
OA (1) | OA10960A (en) |
PL (1) | PL187534B1 (en) |
PT (1) | PT914206E (en) |
WO (1) | WO1998003263A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054580A (en) * | 1996-07-22 | 2000-04-25 | Carnegie Mellon University | Long-lived homogenous amide containing macrocyclic compounds |
US5876625A (en) * | 1996-07-22 | 1999-03-02 | Carnegie Mellon University | Metal ligand containing bleaching compositions |
US5847120A (en) * | 1996-07-22 | 1998-12-08 | Carnegie Mellon University | Long-lived homogenous oxidation catalysts |
CN1267238A (en) * | 1997-06-20 | 2000-09-20 | 卡内基梅隆大学 | Homogeneous oxidation catalyst using metal complexes |
AU751049B2 (en) * | 1998-04-15 | 2002-08-08 | Shell Internationale Research Maatschappij B.V. | Catalyst system for alpha-olefin oligomerization |
US6861262B2 (en) * | 2000-03-03 | 2005-03-01 | Quest Diagnostics Investments Incorporated | Composition and method for detecting an adulterant in an aqueous sample |
GB0020846D0 (en) * | 2000-08-23 | 2000-10-11 | Unilever Plc | Ligands for bleaching compositions and synthesis thereof |
US6797196B2 (en) | 2001-01-10 | 2004-09-28 | Kao Corporation | Bleaching formulation |
GB0118936D0 (en) * | 2001-08-02 | 2001-09-26 | Unilever Plc | Improvements relating to colour-safe fabric treatment compositions |
WO2003014279A1 (en) * | 2001-08-02 | 2003-02-20 | Unilever Plc | Composition comprising macrocyclic tetra-amido metal complex as bleaching catalyst |
GB0205276D0 (en) * | 2002-03-06 | 2002-04-17 | Unilever Plc | Bleaching composition |
GB0205278D0 (en) * | 2002-03-06 | 2002-04-17 | Unilever Plc | Composition comprising macrocyclic tetra-amido N-donor metal-ligand complex as bleaching catalyst |
DE10227774A1 (en) * | 2002-06-21 | 2004-01-08 | Degussa Ag | Use of transition metal complexes with nitrogen-containing multidentate ligands as a bleaching catalyst and bleaching agent composition |
US7060818B2 (en) * | 2003-02-21 | 2006-06-13 | Carnegie Mellon University | Synthesis of macrocyclic tetraamido compounds and new metal insertion process |
BRPI0609349A2 (en) * | 2005-03-03 | 2011-10-18 | South Dakota Soybean Processors | method for producing a vegetable oil derived polyol, vegetable oil derived polyol, method for decreasing the acid value of a vegetable oil derived polyol, and urethane material |
CN100412080C (en) * | 2005-04-06 | 2008-08-20 | 友达光电股份有限公司 | Organo-metallic complex and organic LED and display containing the complex |
EP1926682A4 (en) * | 2005-06-21 | 2012-06-20 | Crosslink Polymer Res | Signal activated decontaminating coating |
CA2632183A1 (en) | 2005-08-25 | 2007-03-01 | Philip R. Houle | Treatment systems for delivery of sensitizer solutions |
US7744749B2 (en) * | 2005-09-08 | 2010-06-29 | Saudi Arabian Oil Company | Diesel oil desulfurization by oxidation and extraction |
US8715489B2 (en) | 2005-09-08 | 2014-05-06 | Saudi Arabian Oil Company | Process for oxidative conversion of organosulfur compounds in liquid hydrocarbon mixtures |
US20090291844A1 (en) * | 2008-05-23 | 2009-11-26 | Lumimove, Inc. Dba Crosslink | Electroactivated film with immobilized peroxide activating catalyst |
US8722881B2 (en) * | 2009-10-13 | 2014-05-13 | Board Of Trustees Of The University Of Arkansas | Method of synthesis of tetradentate amide macrocycle ligand and its metal-complex |
US20150342839A1 (en) | 2010-04-21 | 2015-12-03 | Oraceutica LLC | Compositions and methods for whitening teeth |
RU2012149460A (en) | 2010-04-21 | 2014-05-27 | ДИСКУС ДЕНТАЛ, ЭлЭлСи | METHOD FOR SIMULTANEOUS CLEANING AND WHITENING OF TEETH |
US8584757B2 (en) | 2010-04-21 | 2013-11-19 | Halliburton Energy Services, Inc. | Method and composition for treating fluids before injection into subterranean zones |
US8888489B2 (en) | 2012-10-23 | 2014-11-18 | Oraceutical Llc | Method of simultaneously cleaning and whitening teeth |
US9320580B2 (en) | 2013-04-21 | 2016-04-26 | Oraceutical Llc | Hand-held tooth whitening instrument with applicator reservoir for whitening composition and methods of using same |
MA40390A (en) | 2014-07-25 | 2017-05-31 | Selux Diagnostics Inc | Assay methods involving dissociable nanoparticles |
EP3285924A4 (en) * | 2015-04-24 | 2018-10-03 | Auckland Uniservices Limited | Oxidation method |
AR104939A1 (en) | 2015-06-10 | 2017-08-23 | Chemsenti Ltd | OXIDATIVE METHOD TO GENERATE CHLORINE DIOXIDE |
AR104940A1 (en) | 2015-06-10 | 2017-08-23 | Chemsenti Ltd | METHOD FOR GENERATING CHLORINE DIOXIDE |
WO2017015145A2 (en) | 2015-07-17 | 2017-01-26 | SeLux Diagnostics, Inc. | Dissociable transition-metal nanoparticles |
EP3353157B1 (en) | 2015-09-25 | 2021-11-24 | Carnegie Mellon University | Oxidation catalysts based on macrocyclic compounds |
WO2017100442A1 (en) | 2015-12-08 | 2017-06-15 | SeLux Diagnostics, Inc. | Nanoparticle amplifiers and uses thereof |
AU2017210215B2 (en) | 2016-01-21 | 2022-09-08 | SeLux Diagnostics, Inc. | Methods for rapid antimicrobial susceptibility testing |
RU2653989C2 (en) * | 2016-04-26 | 2018-05-16 | Федеральное Государственное Бюджетное Научное Учреждение Уфимский Федеральный Исследовательский Центр Российской Академии Наук (Уфиц Ран) | Catalyst for producing 3-(3-phenylprop-2-yn-1-yl)-1,3-oxazolidine |
MX2019007653A (en) | 2016-12-23 | 2020-07-29 | Selux Diagnostics Inc | Methods for improved rapid antimicrobial susceptibility testing. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4577042A (en) * | 1983-03-17 | 1986-03-18 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
US4758682A (en) * | 1983-03-17 | 1988-07-19 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4952289A (en) * | 1988-05-09 | 1990-08-28 | Aquanautics Corporation | Macrocyclic amine complexes for ligand extraction and generation |
US4987227A (en) * | 1988-10-21 | 1991-01-22 | The Research Foundation Of State University Of New York | Polyazamacrocycles and their metal complexes |
US5021595A (en) * | 1990-03-02 | 1991-06-04 | Exxon Chemical Patents Inc. | Transition metal catalyst composition for olefin polymerization |
US5847120A (en) * | 1996-07-22 | 1998-12-08 | Carnegie Mellon University | Long-lived homogenous oxidation catalysts |
-
1996
- 1996-07-22 US US08/681,237 patent/US5847120A/en not_active Expired - Lifetime
-
1997
- 1997-07-21 PL PL97331315A patent/PL187534B1/en not_active IP Right Cessation
- 1997-07-21 KR KR10-1999-7000527A patent/KR100491450B1/en not_active IP Right Cessation
- 1997-07-21 AU AU40436/97A patent/AU729102B2/en not_active Expired
- 1997-07-21 AT AT97938014T patent/ATE229372T1/en not_active IP Right Cessation
- 1997-07-21 EP EP97938014A patent/EP0914206B1/en not_active Expired - Lifetime
- 1997-07-21 NZ NZ333797A patent/NZ333797A/en not_active IP Right Cessation
- 1997-07-21 IL IL12815097A patent/IL128150A0/en unknown
- 1997-07-21 CA CA002261589A patent/CA2261589C/en not_active Expired - Lifetime
- 1997-07-21 ES ES97938014T patent/ES2188969T3/en not_active Expired - Lifetime
- 1997-07-21 AP APAP/P/1999/001455A patent/AP919A/en active
- 1997-07-21 DE DE69717819T patent/DE69717819T2/en not_active Expired - Lifetime
- 1997-07-21 DK DK97938014T patent/DK0914206T3/en active
- 1997-07-21 PT PT97938014T patent/PT914206E/en unknown
- 1997-07-21 WO PCT/US1997/012803 patent/WO1998003263A1/en active IP Right Grant
- 1997-07-21 BR BRPI9710513-9A patent/BR9710513B1/en not_active IP Right Cessation
- 1997-07-21 JP JP10507184A patent/JP2000515152A/en not_active Withdrawn
- 1997-07-21 CN CN97198097A patent/CN1121906C/en not_active Expired - Lifetime
-
1998
- 1998-05-12 US US09/076,410 patent/US6100394A/en not_active Expired - Lifetime
-
1999
- 1999-01-20 OA OA9900011A patent/OA10960A/en unknown
- 1999-01-21 NO NO19990268A patent/NO326043B1/en not_active IP Right Cessation
- 1999-11-11 HK HK99105186A patent/HK1020176A1/en not_active IP Right Cessation
-
2006
- 2006-08-02 JP JP2006210959A patent/JP2007016036A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4577042A (en) * | 1983-03-17 | 1986-03-18 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
US4758682A (en) * | 1983-03-17 | 1988-07-19 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
Also Published As
Publication number | Publication date |
---|---|
CN1121906C (en) | 2003-09-24 |
AU4043697A (en) | 1998-02-10 |
JP2007016036A (en) | 2007-01-25 |
NO990268L (en) | 1999-03-22 |
OA10960A (en) | 2001-10-29 |
PL187534B1 (en) | 2004-07-30 |
BR9710513B1 (en) | 2010-10-19 |
ATE229372T1 (en) | 2002-12-15 |
IL128150A0 (en) | 1999-11-30 |
EP0914206A1 (en) | 1999-05-12 |
DK0914206T3 (en) | 2003-04-07 |
NO326043B1 (en) | 2008-09-08 |
AP9901455A0 (en) | 1999-03-31 |
US6100394A (en) | 2000-08-08 |
ES2188969T3 (en) | 2003-07-01 |
PT914206E (en) | 2003-04-30 |
DE69717819T2 (en) | 2003-07-10 |
KR100491450B1 (en) | 2005-05-25 |
PL331315A1 (en) | 1999-07-05 |
CA2261589A1 (en) | 1998-01-29 |
DE69717819D1 (en) | 2003-01-23 |
AU729102B2 (en) | 2001-01-25 |
EP0914206B1 (en) | 2002-12-11 |
HK1020176A1 (en) | 2000-03-31 |
KR20000067993A (en) | 2000-11-25 |
CA2261589C (en) | 2002-10-01 |
WO1998003263A1 (en) | 1998-01-29 |
JP2000515152A (en) | 2000-11-14 |
US5847120A (en) | 1998-12-08 |
NZ333797A (en) | 2000-06-23 |
CN1230903A (en) | 1999-10-06 |
NO990268D0 (en) | 1999-01-21 |
BR9710513A (en) | 2002-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP919A (en) | Metal chelate complexes for foming oxidation catalyst. | |
US6011152A (en) | Synthesis of macrocyclic tetraamido-N ligands | |
WO1999064156A1 (en) | Long-lived homogenous amide containing macrocyclic compounds | |
van der Vlugt | Cooperative catalysis with first‐row late transition metals | |
Bartoszewicz et al. | A Highly Active Bifunctional Iridium Complex with an Alcohol/Alkoxide‐Tethered N‐Heterocyclic Carbene for Alkylation of Amines with Alcohols | |
Nguyen et al. | One-and two-electron reactivity of a tantalum (V) complex with a redox-active tris (amido) ligand | |
Fantauzzi et al. | Nitrene transfer reactions mediated by metallo-porphyrin complexes | |
Bokach et al. | Hydrolytic metal-mediated coupling of dialkylcyanamides at a Pt (IV) center giving a new family of diimino ligands | |
Reiersølmoen et al. | Pyridine‐and Quinoline‐Based Gold (III) Complexes: Synthesis, Characterization, and Application | |
Das et al. | Crystallography of reactive intermediates | |
Schlagintweit et al. | Mixed tetradentate NHC/1, 2, 3-triazole iron complexes bearing cis labile coordination sites as highly active catalysts in Lewis and Brønsted acid mediated olefin epoxidation | |
Mukherjee et al. | Isolation of a novel intermediate during unsymmetrical to symmetrical rearrangement of a tetradentate Schiff base ligand in a manganese (III) complex: Catalytic activity of the rearranged product towards alkene epoxidation | |
Li et al. | Efficient access to a designed phosphapalladacycle catalyst via enantioselective catalytic asymmetric hydrophosphination | |
WO2003057667A2 (en) | Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications | |
Askari et al. | Tuning Inner-Sphere Electron Transfer in a Series of Copper/Nitrosoarene Adducts | |
Van Emelen et al. | C–N coupling reactions with arenes through C–H activation: the state-of-the-art versus the principles of green chemistry | |
Schlachta et al. | Modification of bio-inspired tetra-NHC iron complexes with axial nitrile ligands | |
Ghosh et al. | Reductive nitrosylation and proton-assisted bridge splitting of a (μ-oxo) dimanganese (III) complex derived from a polypyridine ligand with one carboxamide group | |
Damiano et al. | Imido complexes of groups 8–10 active in nitrene transfer reactions | |
RU2173322C2 (en) | Complex compound containing macrocyclic tetradentate ligand, chelate complex and intermediate compound for preparing macrocyclic tetrageniate compounds | |
Ananias et al. | Cleavage of the dimeric cyclopalladated [Pd (N, C-dmba)(μ-X)] 2,(dmba= N, N-dimethylbenzylamine; X= SCN and NCO) by diphosphines. Palladium (II) compounds with distinct structures in the solid-state and in solution | |
US5786496A (en) | High oxidation state metal oxo complexes of the PHAB ligand | |
Oltmanns et al. | Transition metal nitrosyls as nitrosylation agents: VI. Ligand rearrangement between the carbonylmanganese complexes [Mn (CO) 5PR3]+ and [Mn2 (CO) 10− n (Pr3) n], and bis (halogenodinitrosylcobalt) | |
Panda et al. | Nonspectator Feature of Redox Noninnocent Ligands: C––C/C––H Functionalization | |
Kojima et al. | Observation of radical intermediates for unusual carbon-nitrogen bond formation of. alpha.-aminomalonate to give an. alpha.-diamine linkage. ESR studies on electron transfer reactions in cobalt (III)-polyamine complexes |